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ABSTRACT
Complexation of Glycoalkaloid α- Tomatine with Sterols and Its Potential
Application as an Anti-Cancer Drug
Bishal Nepal, Prof. Keith J. Stine (Advisor)
University of Missouri St. – Louis, MO, USA

Glycoalkaloids (GAs) are secondary metabolites found mostly in higher plant
species and some marine invertebrates. They are known to form complexes with 3βhydroxy sterols such as cholesterol causing membrane disruption. So far the visual
evidence showcasing the complexes formed between glycoalkaloids and sterols has been
mainly restricted to some earlier studies using Brewster angle microscopy. This study
aimed to develop a method for topographic and morphological analysis of sterolglycoalkaloid complexes. Langmuir-Blodgett (LB) transfer of monolayers comprising of
glycoalkaloid tomatine, sterols, and lipids in varying molar ratios onto mica followed by
AFM examination was performed. The AFM method used required minimal sample
preparation and allowed visualization of sterol-glycoalkaloid aggregation at nanometer
resolution. While aggregation was observed in a mixed monolayer of tomatine with
cholesterol and mixed monolayers with coprostanol, no sign of complexation was
observed for the mixed monolayers of epicholesterol and tomatine. Similar aggregates
were observed in ternary mixtures of tomatine with cholesterol and phospholipids 1,2dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or egg sphingomyelin (egg SM).
Further, the effect of complexation on membrane integrity was studied using a supported
bilayer composed of DMPC and cholesterol in a 7:3 molar ratio. Disruption of the bilayer
was observed within five minutes of tomatine introduction into the aqueous medium above
the supported bilayer.
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The effectiveness of GAs against various cancer cells are reported in the literature.
One major problem that prevents their practical application is the hemolytic nature of GAs.
The possibility of employing mesoporous silica nanoparticles (MSNs) to circumvent this
problem is explored. MSNs due to their high pore volume and tunable pore size enable
loading of a large volume of molecules. Further surface modification of MSNs provides an
opportunity to design a carrier system compatible with the host body and specific to target
cells. Amino functionalized MSNs (MSN-NH2) coated with polydopamine (PD) and
polyethylene glycol (PEG) were synthesized. The hemolytic activity of the nanoparticles
(NPs) was tested. PD and PEG-coated MSNs showed no sign of hemolysis. Further, the
PEGylation of MSNs resulted in reduced phagocytosis. GA α-tomatine was loaded inside
the pores of MSN-NH2. Thermogravimetry analysis (TGA) indicated a loading of 4.7 %.
The developed drug delivery system (DDS) showed a significant decrease in the hemolytic
activity of α-tomatine. The effectiveness of the DDS was tested against human liver cancer
(HepG2) cells. Cell viability assay suggested the effectiveness of the developed DDS was
comparable to free tomatine. The cells showed signs of late apoptosis. An increase in cell
viability upon the use of, QVD-OPh, a poly caspase inhibitor suggested caspase-mediated
apoptosis might be a plausible cause of cell death.
AFM is a useful tool that finds its application across different branches of science.
In material sciences, AFM is used to characterize the surface properties of materials such
as roughness, and surface coverage. AFM was used for the characterization of nano
porous gold (NPG) the observed structure was comparable to the structure observed
under SEM. Further, the ability of AFM to record three-dimensional data was utilized to
confirm the presence of the anti-cancer drug doxorubicin (DOX) on the surface of NPG.
Further, AFM was utilized to capture images of RBCs and HepG2 cells. The effect of αTomatine on HepG2 cells was also visualized using AFM.
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CHAPTER 1 INTRODUCTION
1.1

Overview
Glycoalkaloids (GAs) from the plant family Solanaceae have been known for their

membranolytic properties. Their affinity towards cholesterol disturbs the interaction of
cholesterol with membrane lipids and hence affects the membrane-stabilizing ability of
cholesterol. Despite several studies, the nature of complexes formed between GAs and
cholesterol is still not understood clearly1. The research aimed to investigate the
complexation between GAs and sterols employing Langmuir monolayers of various
compositions of sterols and lipids as model membranes. Surface pressure-area isotherm
experiments were conducted to study the sterol-GA complexes formed at the air-water
interface. The structure of the complexes formed was investigated using atomic force
microscopy (AFM) on monolayers transferred onto mica supports.
Several recent studies have shown the application of GAs as potential anticancer
drugs. One of the obstacles in using glycoalkaloids as an anticancer drug is their hemolytic
activity. To circumvent this problem, we loaded GA, tomatine inside mesoporous silica
nanoparticles (MSNs) functionalized with pH-sensitive polymers Polydopamine (PD)
which was further decorated with polyethylene glycol (PEG) chains, for the delivery and
release inside cancer cells. The strategy has the potential to serve for targeted specific
delivery of the cargo.
This thesis reports the findings of the projects. Chapter 1 introduces saponins and
GAs, GAs of genus Solanum, complexes of GAs with sterols, and application of GAs in
cancer therapy. The chapter also introduces various model membrane systems developed
for the study of complex biological phenomena. The application of AFM for biophysical
characterization of the model membrane is also briefly discussed. Finally, the application
of MSNs in drug delivery is discussed. Chapter 2 covers materials and methods used
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during the research. Chapter 3 presents results from the AFM study of the complexation
between sterols and the GA tomatine in transferred monolayers. Chapter 4 discusses
results from the synthesis, characterization, and biocompatibility study of MSNs. Chapter
5 presents the result and discussion of MSNs for loading and safe delivery of tomatine for
effective treatment of HepG2 cancer cells in vitro. Chapter 6 presents some preliminary
results in which AFM was used to image RBC and HepG2 cells. The effect of α-Tomatine
on HepG2 cells is also presented. The results here are encouraging and could be potential
projects for future endeavors.

1.2

Saponins and Glycoalkaloids
Saponins are secondary metabolites found primarily in higher plants but also in

some marine invertebrates2. These are amphipathic glycosides and get their name
because of their foaming and emulsifying properties. Saponins are also known to exert
hemolytic activity. The aglycone core of saponins is known as genin or sapogenin. Two
types of sapogenin are known to exist: triterpene and steroid. Both triterpene and steroidal
sapogenin are derived from the same 30-carbon linear precursor, 2,3-oxidosqualene3.
During the process of synthesis steroidal sapogenin loses three methyl groups resulting
in a 27-carbon backbone while triterpene sapogenin retains all 30 carbons in its backbone.
The number of sugar units attached to the aglycone core could vary from 1 to 11, but
saponins with 2-5 sugar units are most common. The sugars can have either linear or
branched arrangements.
Glycoalkaloids have a nitrogen atom incorporated steroidal skeleton as an
aglycone unit, which shares their biosynthetic origin with steroidal sapogenin. The nitrogen
atom can be present either in a ring or in the side chain. Steroidal alkaloids are found in
plants of the family Solanaceae, Liliaceae, Apocynaceae, Buxaceae, and some marine
invertebrates4. They are generally isolated in the glycoalkaloid form. Glycosylated
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steroidal alkaloids have been reported to have antimicrobial and anti-inflammatory
activities5-6. Besides this, several recent studies have suggested glycoalkaloids have
anticarcinogenic activity7-9. All these biological activities make glycoalkaloids a promising
new drug candidate. These compounds are important in plants’ defense mechanisms
against pathogens and pests. They are known to form complexes with cholesterol and
other 3β-hydroxy sterols resulting in membrane disruption and for inhibition of
acetylcholinesterase and butyrylcholinesterase.

1.2.1 Glycoalkaloids of Genus Solanum
The glycoalkaloids from the genus Solanum are widely studied10 and are
representative of this class of alkaloids. Solanum genus includes various commercially
important plants as S. Lycopersicum (tomato), S. tuberosum (potato), and S. melongena
(eggplant).

Figure 1.1 Structure of potato glycoalkaloids Chaconine (a), Solanine (b), and tomato
glycoalkaloid Tomatine (c) The sugar units are D-galactose (pink), D-glucose (orange), Lrhamnose (blue), D-xylose (red). The six-ring steroidal aglycone units are shown in red.
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The GAs can be extracted from flowers, sprouts, stems, and leaves of the plants.
The major glycoalkaloids found in potatoes are α-chaconine and α-solanine (Figure 1.1).
Both α-chaconine and α-solanine have trisaccharides attached at the 3-hydroxyl position
of their aglycone unit. α- chaconine has two L- rhamnose and one D-galactose while αsolanine had one D-glucose, one L-rhamnose, and one D-galactose unit. Most
examinations have shown α-chaconine to exhibit higher biological activity compared to αsolanine. However, the mixture of both glycoalkaloids shows a marked synergistic effect
when used in combination, especially a 1:1 mixture of the two that have shown a significant
increase in membrane-disruptive activity11-12.

α-Tomatine is another

important

glycoalkaloid found in tomato plants (Figure 1.1). The carbohydrate chain of tomatine
consists of two D-glucose, one D-galactose, and one D-xylose unit. The prefix α –
suggests an intact oligosaccharide unit while the prefixes β1-, β2-, γ- and δ- are used upon
hydrolysis of one (either xylose or glucose from the branch), two or three saccharide units,
respectively.
The amount of tomatine is high in green tomatoes which can be up to 500 mg Kg1

but the tomatine content decrease to about 5 mg Kg-1 as the fruit ripens13. The tomatine

content in the vines remains constant at about 500 mg Kg-1. The GA content in the
eggplants was found to be between 0.625-20.5 mg Kg-1 in the 21 varieties studied14. The
GA concentration in potatoes varies widely depending on the type and condition of
cultivation15. The concentration of GA also increases in potatoes upon injury to the plant16.
The reported GA concentration in normal potato tuber is between 12 and 20 mg Kg-1 while
the concentration in green tubers is between 250-280 mg
to have GA content between 1500-2200 mg Kg-117.
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Kg-1

and green skin is reported

1.2.2 Complexation of GAs with Sterols
GAs are known to form 1:1 complexes with 3 β-OH sterols such as cholesterol.
The stoichiometry of complexation with cholesterol has been confirmed by precipitation
experiment18. It was found that intact oligosaccharide was required and removal of one or
more sugar units resulted in a reduction in the ability to form complexes with sterols.
Morphological features such as protrusion and ridges formed due to the complexation
between tomatine and cholesterol have been used to image the presence of unesterified
cholesterol in cells by freeze-fracture scanning electron microscope19-20.
The interaction of GAs with liposomes of different compositions has been studied.
The result from these studies showed that in the presence of 3 β-OH sterols in the
liposome formulation, GAs generally caused the leakage from the liposomes releasing the
encapsulated contents such as dyes or enzymes. Roddick et al. observed that the release
of peroxidase from the liposomes in the presence of tomatine was influenced by the pH
and lipid composition of the liposomes as well as the concentration of tomatine21. The
activity of tomatine was maximal at pH 7.2 and decreased as the pH was lowered to pH
5, probably due to the protonation of steroidal N-atom. The pKa value of N-atom is
reported to be 6.013. The N- atom is therefore protonated at lower pH and is in
deprotonated form at pH > 7. Likewise, for the same concentration of α-tomatine, the
activity was higher for the liposome composed of egg yolk phosphatidylcholine (PC) and
cholesterol than bovine brain sphingomyelin (SM) and cholesterol. A significant increase
in the release of peroxidase was observed with an increase in tomatine concentration from
near 10 µM up to near 100 µM. Similarly, the release of peroxidase from multilamellar
vesicles composed of egg yolk PC and three different sterols – cholesterol, stigmasterol,
or ergosterol induced by solamargine and solasonine was also evaluated22. The activity
of solamargine was found to be significantly higher than solasonine. The combination of
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two GAs in a 1:1 ratio showed a synergistic effect in promoting the lysis of bovine RBC.
Similar synergism was also observed for the release of peroxidase from liposomes made
of egg yolk PC and cholesterol and it was observed that both GAs were ineffective at pH
below neutral23. In another study, it was found that an equimolar mixture of GAs chaconine
and solanine exhibited strong synergism for the release of peroxidase from the liposomes
suggesting the formation of a ternary complex of GAs with cholesterol11. In the same study
it was observed that chaconine was effective at 100 μM and pH 7.2 while solanine did not
show any activity under similar conditions. The activity of chaconine was maximum at pH
8 and solanine showed comparable activity at pH 9. The derivatives obtained by
synthetically modifying the GA solamargine such as the opening of the ring or introduction
of nitroso group did not show membrane disrupting properties24.
A series of studies was conducted by Keukens et al. investigating the effect of the
presence or absence of sterols in membrane disruption by GAs using large unilamellar
vesicles (LUV)25. Various sterols including cholesterol, fucosterol, a sterol found in algae,
and ergosterol, a fungal sterol was incorporated in LUVs along with egg yolk PC. The
LUVs were loaded with 6-carboxyfluorescein and its release upon membrane disruption
was monitored. The GAs did not cause leakage of LUVs without cholesterol. The
effectiveness of different GAs to cause the leakage of cholesterol-containing LUVs
followed the order tomatine> chaconine> solanidine > solanine. It was observed a
minimum of 10 mol % cholesterol is required to promote membrane disruption. Further,
the extent of dye release was found to depend upon the structure of the sterol used. Base
on their observation they proposed a model for the action of GAs on lipid bilayer containing
cholesterol. The first step involved the insertion of GAs into the lipid bilayer between the
acyl chain of lipids. At the cholesterol concentration above the suggested critical value of
10 mol %, a stable GA-cholesterol complex would form due to the interaction between the
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cholesterol rings and the aglycone portion of the GAs. The segregation of complex then
occurs due to carbohydrate–carbohydrate interactions resulting in a region that starts to
protrude outward due to steric demand. Finally, the budding of tubular structure from the
membrane occurs (Figure 1.2).

Figure 1.2 Proposed model for GA induced membrane disruption. Reproduced from
reference1.

The effect of GAs tomatine chaconine and solanine on membrane integrity of
human RBCs, colorectal carcinoma, Caco2, cells, and mitochondria was also
investigated26. The hemolytic activity of the glycoalkaloid was in the order tomatine>
chaconine> solanine determined based on the concentration required to release 50%
hemoglobin. The same order of effectiveness was observed for the promotion of the
release of Ca+2 ions or lactase dehydrogenase from Caco2 cells. The observation
suggested membrane disruption requires significant cholesterol content and the human
RBCs contain about 50% cholesterol. The mitochondrial membrane disruption was
measured by following the release of adenylate kinase.
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1.2.3

Application of Glycoalkaloids in Cancer Therapy
GAs have been extensively studied for their anticancer activity27. Studies have

been conducted either to just determine effectiveness against cell proliferation or to
assessing biochemical mechanisms leading to the observed anti-cancer activity. The
results have suggested GAs act against the cancer cells by promoting apoptosis28,
causing cell cycle arrest29, and inhibiting cell signaling pathways30.
Lee et al. examined antiproliferative activities of glycoalkaloid α-solanine, αchaconine, α-tomatine, their hydrolyzed products, β1- chaconine, β2-chaconine, γchaconine, β2-solanine and aglycones against human colon (HT29) and liver (HepG2)
cancer cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay9. These results showed that all compounds were active, but the activity of
hydrolyzed products was less compared to the glycoalkaloid, indicating the importance of
carbohydrate side chains. It was further observed that the glycoalkaloids were more
effective against the HepG2 cells than HT29 cells. The potencies of α-chaconine and αtomatine against HepG2 were found to be higher than those observed for anticancer drugs
doxorubicin and camptothecin. Friedman et al. performed MTT assays to investigate the
ability of glycoalkaloid α-tomatine, dehydrotomatine, and their respected aglycone
tomatidine and tomatidenol to induce cell death in breast (MCF-7), colon (HT29), gastric
(AGS), and liver (HepG2) cancer cells31. It was observed that tomatine extracts from green
tomatoes were found to be more effective. The IC50 value was found to be lowest against
AGS cells and HT29 cells at 0.03 μg mL-1. In comparison dehydrotomatine, a minor
component from tomato extract with a double bond present between carbon 5 and 6 of
the steroidal B ring, was much less effective with IC50 values of 578 μg mL-1 and 262 μg
mL-1 against AGS and HT29 cells, respectively.
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In another experiment, Lee et al. suggested that α-tomatine might be beneficial
against prostate cancer development and progression7. An EC50 value of 1.67 ± 0.3 μM
was observed against PC3 prostate cancer cells after 24 h of treatment while EC50 value
for the normal prostate cell, RWPE1 was 3.85 ± 0.1 μM. The inhibitory effect was attributed
to induction of apoptosis as was evident from positive Annexin V staining, increased
nuclear condensation, decrease in mitochondrial membrane potential, increased cell
permeability, and cytochrome c expression. Further, the result showed induced activation
of caspase -3, -8, and -9 suggesting the involvement of both intrinsic and extrinsic
apoptosis pathways.
Shieh et al. showed that α-tomatine exhibits antimetastatic activity on human nonsmall cell lung cancer (NCI-H460) cells8. It was found that at a non-cytotoxic concentration
(0.5-1.5 µM) α-tomatine significantly suppressed the abilities of NCI-H460 cells to adhere,
migrate, and invade. The marked reduction in cell migration and invasion suggested a
potential application of tomatine for the treatment of cancer metastasis. Sucha et al.
observed that death of human breast adenocarcinoma, MCF7, cells in the presence of αtomatine at 6 and 9 μM concentration was by necrosis due to membrane disruption caused
by the interaction with cholesterol32. The lack of apoptosis was determined by assay for
proteins p53, p21, and phosphorylated p53. Further, absence in the activity of caspase-8
or caspase-9 supported lack of apoptosis. However, the treated cells showed a loss of
adenosine triphosphate (ATP). It was also observed that for cells treated with 9 μM αtomatine, proliferation was reduced greatly after the initial 24 h; however, by 72 h recovery
in cell proliferation was observed. TEM observations of the cells showed no signs of
blebbing a feature that is common in apoptotic cells but evidence for swelling and
degeneration of nuclear and plasma membranes was visible suggesting necrosis.
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1.3

Biological Membranes
Biological membranes are complex arrangements of lipid bilayers decorated with

proteins, carbohydrates, and their conjugated forms including glycoproteins and
glycolipids that serve as a boundary between the interior of the cell and the external
environment. Biological membranes play important roles in maintaining cell homeostasis
due to their selectively permeable nature33. Membrane proteins and glycoconjugates
attached to the membrane regulate various biological activities such as host-pathogen
recognition, signal transduction, fertilization, immunity, and immune response.

Figure 1.3 Representation of biological membrane showing its complicated nature.
Reproduced from reference34.
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The lipid bilayer is predominantly composed of phospholipids. Phospholipids are
amphipathic molecules consisting of a hydrophobic tail made of fatty acids and a
hydrophilic head with a phosphate group, which can be functionalized with organic
molecules such as choline, serine, or ethanolamine. Phospholipids are of two types glycerophospholipids and sphingophospholipids. In glycerophospholipids, two fatty acids
and a phosphate group are attached to a glycerol molecule as esters while in
sphingophospholipids, a fatty acid molecule and a phosphate head group are attached to
the sphingosine backbone through amide and O-linkage, respectively. Sterols, another
class of lipids, are an important component of the biological membrane. Cholesterol is a
typical animal sterol that comprises about 30% of the animal cell membrane. Cholesterol
plays important role in maintaining membrane fluidity and integrity.

Figure. 1.4 Major lipids found in biological membranes. Reproduced from reference35.
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Cholesterol and sphingolipids are the major components of functional nanoscale
membrane domains named lipid rafts. Lipid rafts are characteristics of outer membranes
and are involved in signal transduction, trafficking of membrane proteins, and regulation
of neurotransmission. Cholesterol is responsible for lateral heterogeneity in lipid bilayers.
This is due to the difference in interaction potential of cholesterol between saturated and
unsaturated lipids. The planarity of the rigid sterol ring favors interaction with saturated
lipids and disfavors interaction with unsaturated lipids36. Cholesterol is also known to
increase the ordering of lipid tails, thicken the bilayer and decrease the lateral area; these
observations are collectively termed condensing effect37.

1.4

Model Membrane System
The complex nature of biological membranes makes them challenging to study.

This necessitated the development of model membrane systems that would mimic
biological membranes and at the same time give researchers control over the parameters
such as composition, size, and structure, making the experimental observations easier to
interpret. The Liposomes of various sizes (small, large, or giant) with one (unilamellar) or
multiple (multilamellar) bilayers and monolayers of lipids at air-water interface are two
models often used to mimic biomembranes38. Liposomes are also studied for their
application as drug delivery vehicle39.

1.4.1 Monolayers as a Model Membrane System: Fabrication and Methods
of Study
Monolayers of lipids are assembled by depositing lipid solution onto the water
surface and subsequent evaporation of the solvent. The choice of solvent is important to
ensure the uniform spreading of the monolayer40. Ideally, a solvent should be volatile,
chemically inert, free of impurities, and with solubilization power enough to dissolve the
solutes under study. It is important to select solvents that are insoluble in the subphase.
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Chloroform and the mixture of chloroform with methanol, ethanol, or acetone are the
commonly used solvents. Other solvents include cyclohexane, benzene, and hexane.
Ultra-pure water or buffer solutions of different pH and compositions are used as
subphase. The uniformly spread single molecule thick film of lipids thus formed is called
Langmuir monolayer named after Irving Langmuir41, who pioneered the technique together
with Katharine B. Blodgett. The lipid composition of the monolayer is chosen to mimic one
of two leaflets of a lipid bilayer.
The monolayer formed then can be studied using different methods some of which
include surface pressure – Area (Π - A) isotherm, surface potential measurement,
Brewster angle microscopy (BAM), transfer of Langmuir film for study by atomic force
microscopy (AFM), fluorescence microscopy, X-ray reflectivity, and scattering, and
infrared spectroscopy.
The surface tension of the water molecule on the subphase decreases when the
monolayer is deposited at the air-water interphase. The difference in surface tension
before and after the deposition of the monolayer is known as surface pressure, Π. The
plot of change in Π Vs A as the monolayer is compressed by closing the barrier at constant
pressure gives Π – A isotherm. Π – A isotherm provides information about molecular
arrangements, phase transitions, compressibility, and stability of the monolayer. A typical
surface pressure isotherm with different phase transition regions is shown in Figure 1.4.
The phase change is noticed by a change in slope in the surface pressure isotherm. The
molecules go from a highly compressible gas-like phase with random orientation of the
hydrophobic tails to a highly oriented solid-like phase in which the hydrophobic tails are
vertically oriented with very low compressibility. Further compression of the molecules
results in the collapse of the monolayer which is visible as a rapid decrease in surface
pressure. Phase diagrams can be constructed from the isotherms recorded at various
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temperature40. Thermodynamic calculations like the excess Gibbs free energy of mixing
(ΔGexc) and free energy of mixing (ΔGmix) can be made from data gathered from the Π – A
isotherms42.
The monolayer formed can be transferred onto the solid support for further
characterization. CaF2 plates are used as solid support for transmission infrared
spectroscopy while SiGe and ZnSe plates are used for internal reflection spectroscopy. A
freshly cleaved mica provides an atomically flat surface for the transfer of monolayer to be
studied using AFM. AFM is useful for the visualization of co-existing phases with great
resolution down to a few nanometers42. The monolayer can be transferred onto the solid
support using two different techniques- a vertical transfer known as Langmuir-Blodgett (LB) method and a horizontal transfer known as Langmuir-Schaefer (L-S) method. Two
different approaches can be used during L-B transfer depending upon the nature of the
substrate (hydrophobic or hydrophilic). Hydrophilic substrates are immersed into the
subphase before spreading the monolayer. The monolayer then is compressed to desired
surface pressure and the substrate is lifted out of subphase at a suitable transfer rate while
maintaining a constant surface pressure. The hydrophobic substrate is immersed in the
subphase after deposition of the monolayer. A series of upward and downward passes
can be conducted to generate multilayer films. If a layer is deposited in every upward and
downward pass, then such transfer is known as Y-type transfer. The other types of transfer
are X-type in which only downward pass is transferred and Z- type transfer in which only
upward pass is transferred40.
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Figure. 1.5 Various steps involved in the preparation and transferring of Langmuir
monolayer. Reproduced from reference43.
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1.4.2 Supported Lipid Bilayers (SLBs) as Model Membrane System
SLBs are another commonly used biomimetic membrane system. SLBs are twodimensional films of lipid bilayer attached to the underlying solid support. It was first
fabricated by Tamm and McConnell in 198544. SLBs has advantages over its predecessor
bilayer membrane, black lipid membrane, in which bilayer is formed across an aperture
(0.1 mm - 1 mm) on hydrophobic materials (polyethylene or Teflon) partitioning two sides
of a chamber filled with an aqueous solvent, for being robust, stable, and amenable to
several characterization techniques45-47.
Fused silica, mica, oxidized silicon, and borosilicate glass are commonly used
substrates for the fabrication of SLBs. L-B transfer or combination of L-B and L-S transfer
technique44 can be used for the formation of SLBs on flat supports. However, the formation
of SLBs by adsorption and fusion of small unilamellar vesicles (SUVs) is commonly
practiced48 (Figure 1.5). SUVs are prepared either by extrusion of multilamellar vesicles
through a polycarbonate membrane with a pore size less than 200 nm or by sonication
and ultracentrifugation of aqueous lipid suspensions. The process of bilayer formation
begins with the adsorption of SUVs onto the solid support. The vesicles then rupture and
fuse giving a planar lipid bilayer (Figure 1.5). The presence of divalent cations such as
Ca+2 or Mg+2 accelerates the process of adsorption49 and helps in the formation of a lipid
bilayer with fewer defects and complete coverage of the substrate. It is also important to
keep the temperature of lipid suspension above the main phase transition temperature of
the lipid used during the entire process of SLB fabrication.
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Figure 1.6 Different methods used for the fabrication of SLBs (right) (a) combination of LB and L-S transfer technique, (b) vesicle fusion (C) L-B/L-S transfer followed by vesicle
fusion. Different processes occurring adsorption and fusion of SUVs on the solid support.
Reproduced from reference45.
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1.5

Atomic Force Microscopy (AFM)
AFM is a type of scanning probe microscope that is used for imaging with

nanometer resolution. AFM was developed in collaboration between IBM (G. Binnig, and
C. F. Quate) and Stanford University (C. Gerber) and the first commercial AFM was
developed by Stanford researchers in 198850-51. AFM consist of a tip of diameter 5-10 nm
attached at the end of the cantilever acting as a probe. The tip scans the surface of the
sample, and the movement of the tip is detected by a position-sensitive detector and is
reconstructed as an image. Based on the nature of the sample the images can be captured
on contact mode (for rigid samples), tapping mode, or non-contact mode (for soft biological
samples).
In contact mode, the cantilever tip is in constant contact with the surface and is
subjected to lateral forces which might result in damage of tip or scratching of the sample.
It is therefore important to determine the minimum setpoint force to be used for acquiring
the images. The selection of a cantilever is also important. Generally, a soft and flexible
cantilever with a low spring constant is required for imaging in contact mode. Since the tip
and sample are always in contact the tip always experiences repulsive force while
operating in contact mode. Determination of cantilever sensitivity is another important step
if quantitative information about tip surface interaction is required. The AFM instrument
does the measurements in terms of potential (V). An accurate cantilever sensitivity which
is the measure of change in potential per unit change in cantilever motion (V nm -1) is
therefore important. Multiplying the cantilever sensitivity with the measured potential
allows us to determine the accurate distance between the tip and the sample. Next, it is
also important to calibrate the cantilever spring constant before each measurement as the
spring constant provided by the manufacturer is not always accurate. The thermal noise
method developed by Hutter and Bechhofer52 is the common calibration method that is
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incorporated with most commercially available AFM instruments and has an uncertainty
of 5-10%. The thermal noise method for calibrating effective spring constant is governed
by the equation:

𝐾=

𝑘𝐵 𝑇
< 𝑞(𝑡)2 >

The unknown parameter <q(t)2>, mean squared displacement of the cantilever is
obtained by integrating the area under the power spectral density curve, which is the
measure of the frequency distribution of <q2(t)>. After which it is possible to measure
interaction forces between the tip and the sample based on Hook’s law F= - displacement
x Spring constant.
Another common mode developed later for imaging soft biological samples
vulnerable to deformation while imaging in contact mode is tapping mode. In this mode,
the cantilever tip is oscillated at its resonance frequency and as the name suggests gently
taps the sample surface. Hard tips with high spring constant and resonance frequency are
used for tapping mode. Initial tunning of the cantilever to determine its resonance
frequency is required. The amplitude of vibration changes as the force experienced by the
tip changes as it comes across different regions of samples with different properties. This
difference in amplitude is then converted to an image.
Images can also be acquired in a non-contact mode in which the tip is brought
close enough to the sample such that an attractive force is established between the tip
and the sample. The change in this attractive force as the tip raster over the sample is
then converted to an image. While the non-contact mode is useful for imaging soft
biological samples it has disadvantages such as high sensitivity to external vibrations and
low image resolution. Therefore, tapping mode is the preferred choice for imaging soft
biological samples.
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Figure 1.7 Different modes of operation in AFM. Reproduced from reference 53.

AFM has several advantages over other imaging techniques such as SEM, TEM,
fluorescent, and confocal laser scanning microscope (LSM)54. The first advantage is that
the images can be acquired either in air, vacuum, or in an aqueous medium unlike in the
cases of SEM and TEM which require high vacuum. The second advantage is the ease of
sample preparation as it does not require fluorescent labeling or coating of conductive
materials. Further, AFM can provide quantitative information such as height distribution of
the sample which is not possible by other methods. Furthermore, the possibility of live cell
imaging under physiological conditions and the ability to combine AFM with other optical
imaging platforms such as fluorescence or confocal LSM has attracted its use in the
biological field.
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AFM is not only used for capturing topographical images. It can also be used to
generate force-distance curves. The force curves than can be used to gather
nanomechanical properties of biological sample55-56. Properties such as stiffness have
been measured in terms of Young’s modulus for a wide range of sample types including
globular proteins, protein filaments, liposomes, viruses, microbes, and eukaryotic cells.
Moreover, the advancement of AFM instrumentation has made it possible to get
information about the interaction between the molecules at the single-molecule level.
Force spectroscopy experiments give valuable fingerprint information on conformational
changes of single polymers57, unfolding and refolding of protein58, type of glycosidic
linkage in particular polysaccharide59, and to measure the forces required to deform and
separate a double-stranded DNA into single strands60.

Figure 1.8 Illustration of different types of force-distance curves showing penetration of
layer upon indentation and rupturing force upon pulling molecule attached to cantilever
tip. Reproduced from reference53.
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AFM has also been utilized effectively to visualize the surface topography of model
membrane lipid domains61. The phase-separated domains when two or more lipids with
different melting points are mixed can be visualized using AFM at nanometer resolution.
The force curves generated on SLBs give information about the force required to rupture
the lipid bilayer, breakthrough force (Fb), which helps understand the strength of bilayers
and how it is affected upon varying composition of lipids or during the interaction of lipid
with other biomolecules such as proteins or drugs. Further, it is also possible to follow
such lipid-protein, lipid-drug interaction, or interaction of lipid bilayer with any molecules
of interest in general over time.

1.6

Mesoporous Silica Nanoparticles (MSNs)
According to of International Union of Pure and Applied Chemistry (IUPAC)

materials with pore sizes between 2 and 50 nm are categorized as mesoporous. The
materials with pore size < 2 nm are designated as microporous and those with pore size
> 50 nm are labeled as macroporous materials62. MSNs were first synthesized by Kresge
et al. from Mobile Research and Development Corporation63. Their method was based on
“liquid crystal templating” in which hexagonally arranged cylindrical micelles were utilized
as a template for the deposition of the silica layer. The template was then removed by
calcination. The resulting a porous material with uniformly arranged hexagonal pores was
dubbed Mobil composition of matter No-41 (MCM-41). The surface area of the synthesized
material was > 1000 m2 g-1 and the pore volume was between 0.7 – 1.2 cm3 g-1. The pore
size of the material could be tuned from 3 – 10 nm by varying the alkyl chain length of the
surfactant.
Since then, different variety of MSNs with different pore orientations and sizes
have been synthesized. Some of which include MCM-48 which has a cubic arrangement
and MCM-50 which has a lamella-like arrangement of pores64. Another type of MSNs
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named Santa Barbra Amorphous type material (SBA-15) was synthesized by a group from
the University of California, Santa Barbra. The group used non-ionic triblock co-polymer
like poly (ethylene oxide) oligomeric surfactant and poly (alkylene oxide) block copolymer
as a template in an acidic medium. SBA-15 differs from MCM-41 in that they have a larger
pore of size 4.6 – 30 nm65. Several other MSNs, SBA-11 (3D cubic), SBA-12 (3D
hexagonal), and SBA-16 (cubic cage structure) were also synthesized the pore symmetry
of which depended upon the type of surfactant used. Other types of MSNs include KIT-5
(Korea Advanced Institute of Science and Technology) with cage type cubic structure66
and COK-12 (Center for Research Chemistry and Catalysis) with hexagonal pore
symmetry67.

Figure 1.9 Illustration of the mechanism of formation of MSNs. Reproduced from
reference68 .

1.6.1 Application of Mesoporous Nanoparticles to Cancer Therapy
Two types of strategies are employed to deliver drug-loaded mesoporous
nanoparticles to the cancer tissues, passive, and active targeting69. Passive targeting
takes advantage of the abnormal vascular structure of tumor tissue, the so-called
enhanced permeability, and retention (EPR) effect. The blood vessels around tumors have
a gap between endothelial cells allowing small nanoparticles with sizes between 30 to 400
nm to leak into the interstitial space of solid tumor tissue68-69. However, the vasculature
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around all tumors does not exhibit the EPR effect therefore passive targeting is not a
reliable approach.
The limitation of passive targeting demanded the development of advanced active
targeting strategies. Cancer cells overexpress folate and transferrin receptors due to their
high folate and iron demand for rapid proliferation. Nanoparticles grafted with folate and
transferrin or antibody specific to these receptors can be used for active targeting of the
cancer cells70-74. Carbohydrates, glycoproteins, aptamers such as sgc8 for targeting
human protein kinase-7(PTK7)75, antibody fragments targeting Her-2 receptor
overexpressed in lungs or breast cancer cells76 are other possible conjugates that could
be attached to nanoparticles for selectively binding with receptors overexpressed on
cancer cells.
The nanoparticles can be cleared from the blood vessels by phagocytic cells
before they reach their targets. The phagocytic cells are triggered by the layer of protein
deposited on the surface of NPs upon their contact with blood. The process of adsorption
of protein is known as opsonization and the layer of protein deposited is known as the
corona. This problem can be circumvented by coating the nanoparticles with polymers like
polyethylene glycol (PEG). PEGylation of NPs shields the NPs from opsonization
preventing phagocytosis and prolonging the systemic circulation time77. Once
nanoparticles reach the cell surface, they are taken in by endocytosis. The
microenvironment near a tumor has a pH of 0.5 – 1 units lower than around normal cells
and pH inside the endosome inside cells can be as low as 4.578. The difference in pH can
be used as a trigger to release drugs. Nanoparticles coated with the pH-sensitive polymer
can be used for the release of drugs.
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1.6.2 Application of MSNs in Drug Delivery
Mesoporous silica nanoparticles (MSNs) because of their high specific surface
area and large pore volume can encapsulate a variety of therapeutic agents. Silica is
approved by FDA as a Generally Recognized as Safe (GRAS) substance and is widely
used in cosmetic products and as a food additive79-80. The fabrication of MSNs is costeffective, scalable, and simple. All these properties make MSNs promising as candidates
for a drug-delivering agent68.

Figure 1.10 Strategies for delivering drugs to cancer site using nanomaterials.
Reproduced from reference69.

The first application of MSNs for drug delivery was reported in 200181 when antiinflammatory drug ibuprofen was loaded inside MSNs. Since then MSNs have been used
as a drug delivery system for several pharmaceutical drugs with different properties such
as water solubility, molecular weight, and biomedical effects81-85 against different diseases
including diabetes86, bone/ tendon tissue engineering87-88 (repairing of the cavity defects
in rabbit femur and Achilles tendon healing in rat) , and inflammation89. Mellaerts et al.
loaded MSNs with poorly water-soluble drug itraconazole and showed that the release of
drug from MSNs in an aqueous environment was faster than the dissolution of a pure
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drug90. They also carried out in vivo experiment in dogs and rabbits and the result showed
a significant increase in systemic availability of the drug. In another experiment, Gu et al.
functionalized the MSNs with carboxyl group for effective loading of cisplatin due to
complexation with the platinum atom91. The drug delivery system showed markedly
prolonged and pH-responsive release of cisplatin. Chen et al. utilized MSNs to co-deliver
doxorubicin (DOX) and siRNA to treat multidrug-resistant cancer cells. They modified the
surface of Dox-loaded MSNs with generation 2 polyamidoamine (PAMAM) dendrimers
which were then complexed with siRNA. In their experiment, they found the efficacy of
Dox increased 132x compared to free Dox to induce cell apoptosis into multidrug-resistant
human ovarian (A2780/AD) cells.
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CHAPTER 2 MATERIALS AND METHODS
2.1 Materials
Cholesterol (>99%) was purchased from Sigma-Aldrich (St-Louis, MO, USA). 1,2dimyristoyl-sn-glycero-3-phosphocholine (DMPC, >99%) and egg sphingomyelin (SM,
>99%) were purchased from Avanti Polar Lipids, Inc (Alabaster, AL, USA). Coprostanol
and epicholesterol were purchased from Steraloids, Inc. (Newport, RI, USA). α-Tomatine
(>95%) was purchased from ChromaDex (Irvine, CA, USA). Cetyltrimethylammonium
bromide (CTAB, ≥99.0%), tetraethyl orthosilicate (TEOS, >99.0%), (3-aminopropyl)
triethoxysilane (99%, APTES), Dopamine hydrochloride (98%) were purchased from
Sigma Aldrich, St. Louis, USA. 5(6)-fluorescein isothiocyanate mixed isomer (FITC, >
95%) was purchased from ThermoFisher Scientific, USA. Tomatine (> 80.0%) was
purchase from TCI America. Amine polyethylene glycol (mPEG-NH2 MW 5000) was
purchased from Laysan Bio Inc., USA. Single donor human red blood cells (RBC) were
purchased from Innovative Research, Inc., Novi, USA. Sodium hydroxide (NaOH,1N),
Hydrochloric acid (HCl, 37%) were purchased from Fisher Scientific, USA. Reagents for
cell culture Eagle’s minimum essential medium (EMEM), fetal bovine serum (FBS),
penicillin-streptomycin solution (Pen-Strep), phosphate-buffered saline (PBS, 1x),
dimethyl sulfoxide (DMSO) were purchased from American Type Culture Collection
(ATCC®) Manassas, USA. All the solvents used, ethanol, methanol, and toluene were
HPLC grade and were purchased from Fisher Scientific, USA. Ultrapure deionized water
with 18.2 MΩ resistivity was obtained using Simplicity® UV water purification system
(Millipore Sigma, USA).

2.2 Sample Preparation
All stock solutions were prepared using HPLC grade solvents and were stored at
-20oC. A fresh batch of solutions was prepared every 15 days. The solutions of sterols and
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lipids were prepared in chloroform and the solution of α-tomatine was prepared in ethanol.
Appropriate volumes of lipids and sterols or lipids, sterol, and tomatine were added to get
the mixtures with desired ratios. The mixtures containing α-tomatine were stirred for an
hour before depositing them onto the subphase. The final percent by volume of ethanol in
the mixtures containing α-tomatine was kept between 8 to 10%.

2.2 AFM Study of Interaction of Tomatine with Lipid Monolayer and
Bilayer
AFM measurements of transferred monolayers were done using NanoScope III
microscope (Digital Instruments, Inc., Santa Barbara, CA) operated in the tapping mode
in air. Silicon probe TAP300AI-G (Ted Pella, Inc., Redding, CA) having a nominal
resonance frequency of 300 kHz, tip radius of < 10 nm, and force constant of 40 N m-1
were used to record topographic images. The ratio of setpoint amplitude to free amplitude
(Asp/Ao) was kept >0.8 to assure softer tapping and avoid sample damaging
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. Images

were captured at a scan rate of 1 Hz using a D-type scanner. The scanner was calibrated
using calibration grating TGQ1 (Ted Pella, Inc.).
BioScope ResolveTM AFM (Bruker, Santa Barbra, CA, USA) was used to observe
complexation formed in the bilayer. Images were captured using SNL-C probes with a
nominal spring constant of 0.12 N/m and a resonance frequency of 23KHz. The images
were acquired using Peak-Force mode in the fluid cell. After determining the deflection
sensitivity, the spring constant of the cantilevers was calibrated using the thermal noise
method. Peak force was set between 1 and 3 nN and images were acquired at a scan rate
of 1 Hz. Force curves were captured by continuously extending and retracting the
cantilever along the z-axis at the rate of 0.5 μm s-1. Images were acquired using a microvolume fluid cantilever holder (Bruker, Santa Barbra, CA, USA).
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2.3 Preparation of Langmuir Monolayer
The mixture of α-tomatine and sterols or α-tomatine, sterols, and lipids were
spread as monolayers on a Langmuir trough containing Milli-Q water as a subphase. The
spread monolayers were then compressed to a surface pressure of 15 mN m -1 after
allowing the spreading solvent to evaporate for 10 min and then transferred onto the
freshly cleaved mica surface using the Langmuir-Blodgett transfer technique. The
transferred layers were then analyzed using AFM operated in tapping mode.

2.4 Langmuir – Blodgett Transfer of Monolayer
Langmuir Blodgett trough (Nima Technology, Coventry, England) was used to
transfer the deposited layer of lipids, sterols, or the mixtures after compressing to surface
pressure of 15 mN m-1. Surface pressure was measured using the Wilhelmy plate method
with a piece of filter paper used as the Wilhelmy plate. Compression was done at a
compression rate of 20 cm2 min-1. The initial surface area of the trough before compression
was 250 cm2. A strip of freshly cleaved mica 10 mm wide and 30 mm long was dipped into
the subphase before injection of samples. The compressed monolayers were transferred
onto the mica at a transfer rate of 4 mm min-1. All the experiments were conducted at room
temperature. The procedures were repeated at least twice to assure reproducibility.
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Figure 2.1 Langmuir – Blodgett trough used for the preparation of monolayer, surface
pressures – area isotherm study, and transferring of a monolayer. The main components
of the instrument are labeled in the image.

2.5 Preparation of Small Unilamellar Vesicles (SUVs)
DMPC and cholesterol were mixed in a 7:3 molar ratio from a stock solution of
concentration 10mg mL-1 prepared in chloroform. The chloroform was evaporated under
a gentle stream of nitrogen gas. The mixture was further dried under a vacuum for one
hour. After one hour the dried mixture was hydrated with 20 mM pH 7.5 HEPES buffer to
get a final concentration of 1 mM. The mixture was incubated for one hour at room
temperature with agitation in between. It was then vortexed to get a milky suspension. The
suspension was passed through three cycles of freeze and thaw. The obtained
suspension was then passed 11 times through a polycarbonate membrane with 50 nm
pore diameter (Nucleopore, Whatman) using an Avanti mini-extruder at 40 oC. The
obtained SUV suspension was then stored at 4 oC and was used within 3 days.
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Figure 2.2 Schematics showing different steps during the preparation of SUVs (A).
Scheme of different components of mini extruder (B) and completely assembled mini
extruder from Avanti Polar Lipid, Inc used for the preparation of SUVs (C).

2.6 Preparation of Supported Lipid Bilayer
180 μL of pre-warmed SUVs suspension and 20 μL of 50 mM CaCl2 were
deposited onto freshly cleaved mica solid support and were incubated for 20 minutes at
40oC. After 20 minutes the SLB was washed three times with 200 μL of 20 mM pH 7.5
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HEPES buffer. The SLB was then observed under AFM using pH 7.5 20 mM HEPES
buffer as an imaging solution.

2.8 Preparation of Surface for Immobilization RBC and HepG2 Cells for
AFM study
Circular glass coverslips (8 mm diameter) were coated with poly-L-lysine (MW 3070 kDa, Sigma Aldrich, St. Louis, USA). The coverslips were incubated for 18 h at 37 oC
in 0.1 mg mL-1 solution of poly-L-lysine prepared in Milli-Q water. 1 mL of the solution was
used to coat the surface of 25 coverslips, the volume was estimated from the manufacturer
protocol which recommended 0.5mL of 0.1 mg mL-1 for a surface of 25 cm2. After 18 h the
solution was vacuum aspirated, and the coverslips were then rinsed with a copious
amount of Milli-Q water. The coverslips were then dried and stored at 4 oC until further
use.
For immobilization of RBC, 100 µL 5% (v/v) dilute RBC was pipetted on the on
poly-L-lysine coated glass surface. The RBC solution was kept for 30 min at room
temperature allowing the RBCs to adhere to the surface. It was then rinsed with PBS and
was fixed with 3.7% glutaraldehyde for 5 min. It was then rinsed with PBS to remove
glutaraldehyde.
Similarly, for AFM imaging of HepG2 cells, the cells were incubated in 24 well
plates at a seeding density of 75,000 cells well-1 in complete EMEM for 24 h. The cells
were then treated with 1 mg mL-1 α-tomatine solution prepared in 0.1% DMSO for 1 h. The
untreated cells were used as a control. After 1h the growth medium was aspirated, the
cells were then incubated in 100 µL of Trypsin- EDTA for 1 min. The detached cells were
collected in a centrifuge tube and were centrifuged at 0.2 rpm for 10 min the supernatant
was discarded the cells were then resuspended in 100 µL 3.7 % formaldehyde for fixing
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for 5 min. After 5 min the cells were centrifuged, the formaldehyde was discarded, and the
cells were resuspended in PBS. The cells were then immobilized in a poly-L-lysine coated
glass surface as described above.
AFM images were acquired in the fluid cell using BioScope ResolveTM AFM
(Bruker, Santa Barbra, CA, USA) and PBS was used as an imaging buffer. The images
were acquired in contact mode using SNL-C probes with a nominal spring constant of 0.12
N m-1 and a resonance frequency of 23 KHz.

2.7 Synthesis of MSNs
MSNs were synthesized using the modified Stober method. Briefly, 1 g of CTAB,
480 mL of H2O, and 7 mL of 1 N NaOH were taken in a round-bottom flask, the mixture
was heated to 80 oC and stirred vigorously until CTAB was completely dissolved giving a
clear solution. After that, 5 mL of TEOS was added to the mixture dropwise while
continuous magnetic stirring resulting in a white cloudy solution. The obtained mixture was
left stirring for 2 h at 80 oC. The mixture was then vacuum filtered, washed with a copious
amount of H2O and ethanol. The obtained product was left to dry under a vacuum for 24
h. 1 g of the dried powder was then calcined at 600 oC for 1 h followed by acid extraction,
refluxed with 100 mL of 1 % HCl in ethanol for 24 h, to remove CTAB. Thus, synthesized
MSNs was vacuum filtered and washed with a copious amount of ethanol, dried under
vacuum for 24 h, and was stored at 4 oC until further use.
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Figure 2.3 The synthesis of MSNs.

For the study of the internalization of NPs by different cells by confocal laser
scanning microscopy (LSM), fluorescein-labeled MSNs were synthesized. For this
purpose, 3.8 mg of FITC was mixed with 330 μL of ethanol and 70 μL of APTES and was
magnetically stirred for 2 h. After 2 h, 100 μL of the reaction mixture was added after 5 mL
of TEOS as described above.

2.8 Synthesis of Amino Functionalized MSNs (MSN-NH2)
500 mg of MSNs was mixed with 0.6 mL of APTES and 10 mL of toluene and was
stirred for 24 h at 100 oC under reflux. The mixture was then vacuum filtered and washed
with a copious amount of toluene, ethanol, and methanol. The obtained product was then
dried under vacuum for 24 h and stored at 4 oC until further use.

2.9 Loading of Tomatine in MSN-NH2 (MSN-NH2@Tom)
2 mL of a highly concentrated solution of tomatine, 7.2 mg mL-1 was added to 50
mg of MSN-NH2 giving the mass ratio of MSN-NH2 to tomatine at 3.5: 1. The mixture was
sonicated for 30 minutes and then was refluxed for 18 h. The mixture was then centrifuged
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and washed three times with ethanol to get rid of excess tomatine. The prepared NPs
were dried under a vacuum for 24 h and stored at 4 oC until further use.

2.10 Polymer coating of MSN-NH2-Tom, MSN-NH2-Tom@PD, and
MSN@Tom
Polydopamine coating of tomatine-loaded NPs was done by adding 50 mg of MSNNH2-Tom to 50 mL of 1 mg mL-1 dopamine prepared in 10 mM pH 8.5 Tris-HCl buffer
immediately before MSN-NH2-Tom addition. The mixture was then magnetically stirred for
18 h followed by centrifugation and washing with Milli-Q H2O three times to remove excess
polydopamine, dried under vacuum for 24 h, and stored at 4 oC until further use. NPs
without tomatine were also coated with polydopamine using the same protocol and are
designated as MSN-NH2@PD.
PEGylation of MSN-NH2-Tom@PD was achieved by adding 20 mg MSN-NH2Tom@PD to 8 mL of 5 mg mL-1 mPEG-NH2 prepared in 10 mM pH 8.5 Tris-HCl buffer
immediately before MSN-NH2-Tom@PD addition. The mixture was then magnetically
stirred for 18 h followed by centrifugation and washing with Milli-Q H2O three times to
remove excess mPEG-NH2, dried under vacuum for 24 h, and stored at 4 oC until further
use. NPs without tomatine were also PEGylated using the same protocol and are
designated as MSN-NH2@PD/PEG.

2.11 Characterization techniques
Scanning electron microscopy was done using JEOL JSM-6320F field emission
SEM (JEOL USA, Inc., MA, USA) images were acquired at a working distance of 8 mm
and an acceleration voltage of 8 kV. The morphology of NPs, arrangement of mesopores,
and polymer coating were studied using Thermo Fisher Scientific G2 field emission gun
transmission electron microscopy (FEG-TEM) operated at 100 kV. Powder X-ray
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diffraction (XRD) was carried out using Ultima IV, Rigaku X-ray diffractometer equipped
with Cu Kα radiation (λ=1.5406 Å). Brunauer-Emmett-Teller (BET) surface area analysis
and Barrett-Joyner-Halenda (BJH) pore size and pore volume analysis were done using
Beckman Coulter SA-3100 Gas Adsorption Surface Area and Pore Size Analyzer
(Beckman Coulter, Inc., CA, USA). Thermogravimetric analysis (TGA) was performed in
TGA Q500 (TA Instrument, Inc., DE, USA) with 15 oC min-1 heating ramp from 25 oC to
700 oC. FTIR- attenuated total reflection (ATR) (Thermo Fisher Scientific, MA, USA) was
used to characterize functionalization and tomatine loading.

2.12 Hemolysis Assay
1 mL of RBC was centrifuged at 2000 rpm for 5 min, then the supernatant was
discarded, and the process was repeated until a clear supernatant was obtained. The
packed RBC was further diluted to a 5% (V/V) solution. 200 μL of 5% RBC dispersion was
added to 800 μL of nanoparticle suspensions of different concentrations prepared in PBS.
The mixture was incubated for 2 h at 37 oC with gentle mixing by inversion every 30 min.
After 2 h the mixtures were centrifuged, and the absorbance of the supernatant was
measured at 541 nm using a Cary 50 UV–Vis spectrophotometer (Agilent, CA, USA). PBS
and DI water were used as the negative and positive control, respectively. Solutions of atomatine were prepared in 0.1% DMSO. Hemolytic activity of 0.1% DMSO was tested as
vehicle control.

2.13 Cell Culture
HepG2 cells (ATCC®, Manassas, VA) were seeded into each well of 24-well plates
at a seeding density of 75,000 cells well-1 in 1 mL EMEM containing 10% FBS and 1%
penicillin-streptomycin. The cells were incubated for 24 h at 37 oC in a humidified
atmosphere of 5% CO2 to allow attachment to wells. The cells were then incubated with
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NPs at varying concentrations for 24 h. Cells incubated without nanoparticle and with
0.05% TritonX-100 were used as a positive and negative control, respectively.
For confocal LSM cells were first seeded on 35 mm MatTek glass bottom dishes
with 14 mm coverslip at a seeding density of 2 x 105 cells per dish. Confocal images were
acquired using Zeiss LSM 900 and analyzed using ImageJ.

2.14 Cell Viability Assay
Cell viability was assessed using the CellTiter 96® Aqueous One Solution Cell
Proliferation Assay (Promega, Madison, WI, USA). The reagent contains a tetrazolium
compound,

3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-

2H-tetrazolium salt (MTS), and an electron coupling reagent, phenazine ethosulfate
(PES). PES has enhanced chemical stability, which allows its combination with MTS to
form a stable solution. Tetrazolium compound, MTS is reduced by viable cells to generate
a colored formazan dye that is soluble in cell culture media. The absorbance of formazan
dye was quantified at 490 nm. Briefly, 30 μL of assay reagent was added after 24 h of
incubation with tested materials to each well and was further incubated for 3 h. After 3 h
the absorbance at 490 nm was measured with Wallac 1420 multilabel counter
(PerkinElmer™, Finland).
Solutions of α-tomatine were prepared in 0.1% DMSO and cells treated with 0.1 %
DMSO was used as vehicle control. IC50 was calculated by fitting the data to a fourparameter non-linear dose-response regression model using GraphPad Prism 9.1.0.

2.15 Study of Cellular Internalization of MSN-NH2@PD/PEG
The internalization of NPs by cells was confirmed by visualization with confocal
LSM. 100 μg mL-1 of fluorescein-labeled MSN-NH2@PD/PEG were incubated for 3 h with
HepG2 cells. After 3 h cells were washed three times with sterile PBS and fixed with 3.7%
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formaldehyde. The actin filaments were stained with Phalloidin-iFluor 555 and DAPI was
used to stain nuclei.

2.16 Study of Phagocytosis of NPs by THP-1 Macrophages
Phagocytosis of NPs was studied using differentiated human peripheral blood
monocytes, THP-1, cells (ATCC®, Manassas, VA). Briefly, THP-1 cells were incubated in
an RPMI medium containing 10 nM Phorbol 12-myristate-13-acetate (PMA) for 24 h. After
24 h the medium was changed, and cells were incubated with 100 μg mL-1 of fluoresceinlabeled NPs for 3 h. To ensure the formation of protein corona NPs were incubated in the
growth medium with 10% FBS for 1 h before incubating with THP-1 macrophages.
Nanoparticle suspension prepared in a growth medium without FBS was used as a control
(non-corona forming condition). The cells were then fixed, stained, and visualized with
confocal LSM as above.

2.17 Apoptosis/Necrosis assay
Apoptosis/Necrosis Detection Kit (Abcam Inc.) was used to monitor apoptotic,
necrotic, and healthy cells following the manufacturer's protocol. Briefly, after 24 h of
incubation with NPs, HepG2 cells were washed with 100 μL assay buffer provided with
the kit twice after which 200 μL of assay buffer was added to the cell followed by 2 μL of
Apoxin Green indicator, 1 μL of 7-AAD and 1 μL of CytoCalcein 450. The cells were
incubated for 30 min at room temperature and then washed with assay buffer finally 200
μL of assay buffer was added to the cells and were visualized using confocal LSM.

2.18 Caspase Inhibition Assay
The effect of caspase inhibition on cell viability was studied using QVD-OPh, a
caspase inhibitor (Abcam Inc.). Briefly, 1μM of QVD-OPh was added to cells along with
MSN@Tom, and the viability of cells was tested after 24 h of incubation.
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2.19 Data analysis
AFM images were analyzed using Gwyddion software93. Images were first
flattened and corrected for scan line artifacts applying a polynomial function of first to third
order. Height histograms were extracted after initial image processing. Solver, a Microsoft
Excel add-in program, was used to fit the height distribution to a multi-peak Gaussian
model using the non-linear least square minimization method 94. The first peak of the fitted
curve was set to zero. The standard deviation of measurements was obtained from the
fitted parameter.
Results are presented as mean ± SEM. Statistical significance of variables
between two groups was determined using unpaired t-test and two-way ANOVA followed
by post hoc Tuckey’s test was done for statistical evaluation of data with more than two
groups. A value of p < 0.05 was considered significant.
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Chapter 3 ATOMIC FORCE MICROSCOPY STUDY OF THE
COMPLEXATION OF STEROLS AND THE GLYCOALKALOID αTOMATINE IN SUPPORTED MONOLAYERS AND BILAYERS
3.1 Introduction
Glycoalkaloids (GAs) are a class of natural products containing an Nincorporated steroidal skeleton coupled to one or more saccharide units. The
pharmacological properties of GAs have been well established. They are known to
exhibit antifungal, anti-inflammatory, and antimicrobial activity. In recent years, the
potential application of GAs against cancerous cells is being explored extensively

95-

96

. Several in vitro and in vivo studies carried out on various cancer cell and animal

models have shown promising results. Cellular assays have been performed to
understand the mechanism of cytotoxicity. These studies have revealed glycoalkaloids
can induce apoptosis, cause cell cycle arrest, and inhibit various cell signaling
pathways and proteins.
GAs are also known to form complexes with 3β-hydroxy sterols such as
cholesterol. Their affinity towards cholesterol disturbs the interaction of cholesterol
with membrane lipids and hence affects the membrane-stabilizing ability of
cholesterol, compromising the membrane integrity. Earlier experiments showing
leakage of enzymes or dyes encapsulated in the liposomes consisting of 3β-hydroxy
sterols upon treatment with GAs are suggestive of this fact 1, 21. In more recent studies
membrane disruption of cancer cells resulting in its necrosis was attributed to complex
formation between cholesterol and the GA

32

. Despite several studies, there is very

little literature reporting high-resolution visual evidence of the complexes formed
between GAs and sterols. Earlier studies using Brewster angle microscopy (BAM) of
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tomatine injected beneath spread monolayers of 1,2-dimyristoyl-sn-glycero-3phosphocholine (DMPC) and cholesterol clearly showed increases in surface pressure
together with the onset of aggregate formation at the water-air interface but the method
did not allow good resolution of the aggregates97-98 as the BAM resolution was at best
several microns. Visualization of the morphology and topography of these complexes
with nanometer resolution could provide aid in understanding the biophysical and
biological properties of GAs and how they interact with biological membranes.
Herein we report a simple method to effectively capture and visualize the
structures of the complexes formed between GAs and sterols. The complexation of
the GA α-tomatine with three different sterols, cholesterol, coprostanol, and
epicholesterol, alone or in combination with two different lipids DMPC and egg
sphingomyelin (egg SM) were investigated (Figure 3.1). α-Tomatine is an important
glycoalkaloid found in leaves, stems, and fruits of tomato plants. Green tomatoes can
have up to 500 mg kg-1 of tomatine. The tomatine content decreases to about 5 mg
kg-1 upon ripening of the fruit

. α-Tomatine has a branched carbohydrate chain,
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consisting of two D-glucose, one D-galactose, and one D-xylose unit, attached to the
steroidal skeleton, at the 3-hydroxyl position. The prefix α – suggests an intact
oligosaccharide unit while the prefixes β1-, β2-, γ- and δ- are used upon hydrolysis of
one (either xylose or glucose from the branch), two or three saccharide units,
respectively.

60

Figure 3.1 Structure of GA α-Tomatine (A), phospholipids DMPC (B) and SM (C), sterols
cholesterol (D), coprostanol (E), and epi-cholesterol (F).

The mixture of α-tomatine and sterols or α-tomatine, sterols, and lipids were
spread as monolayers on a Langmuir trough containing Milli-Q water as subphase.
The spread monolayers were then compressed to a surface pressure of 15 mN m-1
after allowing the spreading solvent to evaporate for 10 min and then transferred onto
the freshly cleaved mica at the transfer rate of 4mm min-1 surface using the LangmuirBlodgett transfer technique. The transferred layers were then analyzed using AFM
operated in tapping mode.
Further, as a comparison, the effect of α-tomatine on membrane integrity was
observed under physiological conditions using a supported lipid bilayer composed of
DMPC: Chol in the molar ratio 7:3. Rapid disruption of the membrane was observed
within 5 min of injection of a 10 μM solution of α-tomatine above the supported lipid
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bilayer using an AFM liquid cell. Figure 3.2 shows the synopsis of the procedure used
in this project.

Figure 3.2 Various experimental procedures, Π-A isotherm, transfer of monolayer formed
at the air-water interface, preparation of SLB and AFM study in air and fluid medium

3.2 Results and Discussion
3.2.1 Langmuir-Blodgett transfer experiments
3.2.1.1 Sterol: α-tomatine interaction
During initial investigations, deposited layers composed of cholesterol and αtomatine mixed at different molar ratios were transferred onto the mica. AFM images of
the transferred layers showed the presence of aggregated structures (Figure 3.3 and
Figure 3.4) suggesting the method was successful in capturing the complexes formed.
These aggregates are composed of collections of 1:1 complexes between α-tomatine and
cholesterol. The transferred monolayer of cholesterol alone was uniform with RMS
roughness (Sq) of 0.040 ± 0.003 nm whereas, there was an increase in roughness, Sq =
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0.132 ± 0.003 nm, for the transferred layers composed of an equimolar mixture of
cholesterol and α-tomatine. The AFM image also showed the presence of porous defects.
The deposited layer consisting of cholesterol and α-tomatine at three different molar ratios,
1:2, 2:1, and 4:1, were then analyzed. AFM images showed the presence of dark (lower
height) and bright (higher height) regions with height differences of nearly 0.8 nm. The
bright clusters were separated further apart and appeared more straw-like with the
increment in moles of cholesterol. It is well established that α-tomatine forms a 1:1
complex with cholesterol. The stoichiometry of complexation with cholesterol has been
confirmed by precipitation experiment18. Therefore, the fraction of components forming
complexes in the case of the mixtures of cholesterol and α-tomatine in 1:2 and 2:1 molar
ratio should be the same. The excess cholesterol left after complexation in the 2:1
cholesterol – tomatine mixture might help retain the complex formed. Likewise, in the case
of 1:2 molar ratio, the excess molecules after complexation would be α-tomatine which
might be lost in the subphase which could explain the large porous defects observed AFM
image (Figure 3.3). While the fraction of components forming complexes in the case of the
4:1 mixture is less which might have resulted in the separation of aggregates into more
clearly identifiable straw-like structures dispersed in the matrix of the excess of cholesterol
left after complexation.
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Figure 3.3 AFM topography image of Cholesterol (A) and Cholesterol: Tomatine deposits
at different molar ratios 1:1 (B), 1:2 (C) 2:1 (D) and 4:1 (E) transferred at 15 mN m-1. A
comparison of height distribution in C, D, and E is shown in F. The green box 500 nm x
500 nm was selected for roughness comparison.

It is important to note that spread solutions of α-tomatine alone prepared in 9:1
chloroform – ethanol mixture did not result in the formation of monolayer indicated by the
very minimal rise in surface pressure during the compression. The mixture of cholesterol
and tomatine did however resulted in the rise of surface pressure. Several previous
studies have demonstrated that non-amphiphilic molecules that normally do not form a
stable monolayer at the air-water interface were able to form easily transferable stable
monolayers upon mixing with fatty acids100-103. It was inferred that at low concentration the
non-amphiphilic molecules were accommodated in the excess fatty acid matrix and at high
concentration, non-amphiphilic molecules were likely squeezed out of the air-water
interface and remained sandwiched between the fatty acid chain and on the surface of the
monolayer. The conclusion was made based on the pressure–area isotherm, which
showed an initial increase and then a decrease of average area per molecule with an
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increase in the mole fraction of non-amphiphilic molecules. Based on the nature of
pressure-area isotherms and the AFM images observed we assume a similar mechanism
might be occurring in the mixed monolayer of tomatine and cholesterol.
The isotherm for the cholesterol - tomatine mixtures with a low fraction of
cholesterol (cholesterol: tomatine at 1:2 and 1:1) resembled that of cholesterol with a
sharp rise in slope but had high collapse pressure above 50 mN m-1 (Figure 3.4). The
nature of the isotherms for the mixtures with a higher fraction of cholesterol (cholesterol:
tomatine at 2:1 and 4:1) were similar with less steep slopes. Similar observations were
made previously where the spreading and compression of tomatine at the air-water
interface exhibited a minimal rise in surface pressure and did not show any transitory
features under BAM97. The interaction between tomatine and cholesterol was effective at
retaining tomatine at the interface and the retention was more pronounced at higher
cholesterol concentrations.

Figure 3.4 Pressure – area isotherms for the binary mixtures of cholesterol and α-tomatine
and cholesterol (A), and ternary mixtures of cholesterol, α-tomatine, DMPC (B) and
cholesterol, α-tomatine, egg SM (C) at different molar ratios.

A further effect of variation in sterols structure on the morphology of the complex
formed was studied using two different sterols coprostanol and epicholesterol.
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Coprostanol differs from cholesterol in having a non-planar ring system and saturation of
double bond while epicholesterol has an inversion of stereochemistry from 3β-OH to 3αOH. The ratio of sterols to α-tomatine was kept at 2:1. The structure of the aggregates
observed for mixed monolayers of coprostanol and α-tomatine were shorter and more
granular in comparison to those seen in the cholesterol - α-tomatine mixture observed at
the same molar ratio (Figure 3.5). In contrast, no aggregated structures were visualized
for 1:2 α-tomatine – epicholesterol mixtures. The lack of observation of aggregates upon
combining α-tomatine and epicholesterol is consistent with the earlier report of a lack of
aggregate formation seen by Brewster angle microscopy when a-tomatine interacted with
spread monolayers containing epicholesterol. The stereochemistry of the 3-OH group is
clearly crucial for complex formation.
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Figure 3.5. AFM topography image and height distribution analysis of cholesterol: tomatine
(A, B) and coprostanol: tomatine deposits at molar ratio 2:1 transferred at 15 mN m-1.

3.2.1.2 DMPC + sterol: α-tomatine interaction
The effect of lipids on the interaction between sterol and α-tomatine was then
investigated as the most significant aspect of GAs is their interaction with both natural and
model membranes. Two different lipids, DMPC and egg SM was chosen for the study.
DMPC forms a stable monolayer and remains only in liquid - expanded (LE) phase
throughout compression, which is apparent from the lack of plateaus in its pressure-area
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isotherm (Figure 3.5). The mixture of cholesterol and DMPC is known to co-exist in an
immiscible liquid phase below a certain temperature-dependent critical pressure in a
monolayer at the air-water interface
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. To avoid the transferring of phase-separated

domains and obtain a uniform liquid-expanded phase, the transfer experiments were done
at 15 mN m-1, a surface pressure well above the critical pressure. AFM analysis showed
clear evidence of phase-separated domains of cholesterol and DMPC when transferred
at a lower surface pressure (Figure 3.6). The domains were more pronounced when the
cholesterol content in the binary mixture was increased from 30 mol% to 50 mol%. The
domains appeared to fuse and form a uniform liquid phase when the monolayers were
compressed to a surface pressure of 15 mN m-1. Uniformity of the transferred monolayers
was desired for any changes observed in the uniform monolayer seen upon the
incorporation of α-tomatine can then be attributed to the added α-tomatine.

Figure 3.6 Surface pressure -area isotherm for cholesterol, DMPC and their mixtures at
different molar ratios (A) and cholesterol, egg SM and their mixtures at different molar
ratios (B)
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Figure 3.7 AFM topography images of monolayers composed of DMPC: Cholesterol 7:3
transferred at 9 mN m-1 (A) and 15 mN m-1 (B). DMPC: Cholesterol 1:1 at 9 mN/m (C) and
15 mN m-1 (D)

For the ternary mixture of DMPC, cholesterol, and tomatine, three different
compositions were studied. The structures observed in the mixture composed of 7:1:2
DMPC: cholesterol: tomatine were different in appearance compared to structures
observed in DMPC: cholesterol: tomatine mixture of composition 7:1.5:1.5 and 7:2:1
(Figure 3.7). The structures in 7:1:2 mixtures seemed to be formed of straw-like
strands bundled together. While the straw-like strands in the 7:1.5:1.5 and 7:2:1
mixtures were seen to be further apart.
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Figure 3.8. AFM topography images and height distribution analysis of the deposits
composed of a ternary mixture of DMPC: Cholesterol: Tomatine at 7:1:2 (A, D), 7:1.5:1.5
(B, E), and 7:2:1 (C, F) transferred at 15mN m-1.

Interestingly, no aggregates were observed for the transferred monolayers in
which cholesterol was replaced by coprostanol for two different compositions studied,
DMPC: coprostanol: tomatine of molar ratios 7:2:1 and 7:1:2. The transferring of the
monolayer was done at 15 mN m-1 surface pressure. The result indicates the presence
of DMPC affects the interaction between α-tomatine and coprostanol. Keukens et al.
previously have reported complete loss of membrane disruption when cholesterol was
replaced by coprostanol in large unilamellar vesicles composed of egg yolk
phosphatidylcholine, egg yolk phosphatidic acid, and sterol in the molar ratio of 6.5:0.5:3
as indicated by lack of 6-Carboxyfluorescein leakage from the vesicles1.
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3.2.1.3 SM cholesterol α-tomatine interaction
Both SM and DMPC have phosphatidylcholine as a head group but unlike DMPC,
SM has a sphingosine base as the backbone and the fatty acid is amide linked. SM acts
as both hydrogen bond donor and acceptor and SM is known to interact with cholesterol
resulting in the formation of lipid rafts on the biological membrane. The addition of αtomatine to egg SM and cholesterol mixture would mean α-tomatine would need to
compete with SM to interact with cholesterol and the result of such competition on the
structure should be an interesting observation.
The AFM image of the monolayer of egg SM transferred at 15 mN m-1 presence
of small and large circular domains was observed (Figure 3.8). Smaller domains ranged
from 180 to 400 nm in size while the larger domains were around 5 μm. The average
height of such domains was 0.4 ± 0.1 nm. Further, at higher surface pressure (30 mN m1

), the egg SM monolayer exhibited uniform distribution of thin ribbon-like ligaments, with

an average width of 57 nm and an average inter ligament distance of 55 nm (Figure 3.10).
Similar phase-separated domains were reported by Weeraman et al.103 The reported
height of the domains was 0.4 to 0.7 nm which is similar to the height observed in the
present study. Slotte previously observed that for N-palmitoyl sphingomyelin (N-P-SM)
and cholesterol mixtures the lateral boundary between LE and liquid condensed (LC)
phase dissipated with increased surface pressure or cholesterol concentration105. The
surface pressure required for the merger of the LC phase ranged from 3 mN m-1 to 12
mM m-1 depending upon the cholesterol concentration. For cholesterol concentration of
35 mol%, the mergers of the LC phase were observed at 12 mN m-1. AFM topographic
images of SPM: cholesterol monolayer at 7:3 molar ratio transferred at 15 mN m -1
revealed such merging of LC domains (Figure 3.10). In the topography image of SPM:
cholesterol monolayer at 8.5:1.5 molar ratio, two morphologically different LC domains
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were observed. The large circular domains protruded 0.5 ± 0.3 nm above the ribbon like
domains that were 0.6 ± 0.3 nm above the surface. A similar observation was reported
by Slotte for N-P-SM and cholesterol mixture composed of 20 mol% cholesterol. It is
important to note that Slotte used the epifluorescence microscopy for the visualization of
lateral monolayer domains and thus scale of observations is at least 50-fold lower in
magnification in comparison to the present study.

Figure 3.9. AFM topography images and height distribution analysis of the deposits
composed SM (A, D), SM: cholesterol at 8.5:1.5 (B, E), and SM: Cholesterol: Tomatine at
6:2:2 (C, F) transferred at 15mN m-1.

For the ternary mixture of SM, cholesterol, and tomatine, no sign of aggregation
formed between cholesterol and tomatine was observed initially for two different
compositions studied, SM : cholesterol : tomatine molar ratios of 7:2:1 and 7:1:2. Further,
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the monolayer transferred showed the presence of phase-separated domains and the
nature of the domains were comparable to the domains observed in binary mixture of SM
and cholesterol. The topography image of the ternary mixture of the ratio 7:2:1 was like
the binary mixture of the ratio 7:3 and the ternary mixture of ratio 7:1:2 was comparable
to a binary mixture of 8.5:1.5 (Figure 3.9 and Figure 3.10). The result indicated for the
compositions taken the interaction between cholesterol and SM was strong and prevented
tomatine from interacting with cholesterol. Upon increasing the fraction of tomatine and
decreasing the fraction of SM for the ternary mixture (SM: cholesterol: tomatine 6:2:2) the
aggregation of the cholesterol tomatine complex was visible in the transferred monolayer.
The interesting observation was the absence of the circular domain as seen in the SM and
cholesterol binary mixture or the ternary mixture of SM, cholesterol, and tomatine with the
previous composition (Figures 3.9 and 3.10). The lack of these circular domains suggests
that these domains might have been composed of SM and cholesterol and the addition of
tomatine replaced SM from such domains. SM and cholesterol are well-known to form
such domains in biological membranes, called lipid rafts, that are involved in important
biological functions such as protein trafficking and signal transduction36, 106.
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Figure 3.10. AFM topography images of the monolayer of SM transferred at 30 mN m-1
(A), SM: cholesterol at 7:3 (B), SM: Cholesterol: Tomatine at 7:2:1 (C) and 7:1:2 (D)
transferred at 15 mN m-1.

3.2.2 Experiment on supported lipid bilayer
AFM has an advantage over other imaging techniques such as transmission
electron microscopy and scanning electron microscopy as images can be captured under
physiological conditions. To visualize the effect of GA and sterol complexation on the
integrity of a membrane an in-vitro experiment was designed. SLB composed of DMPC
and cholesterol in a 7:3 molar ratio was used as a model membrane system. The details

74

about vesicle preparation supported bilayer formation, and imaging conditions are
explained in the experimental section.
The bilayer prepared although did not show complete coverage of the mica
surface. However, the circular patches of the bilayer of size 1 to 2 μm were large enough
to run the experiment (Figure 3.11). To confirm the observed patches were of lipid +
cholesterol bilayer, a force curve was generated on the selected area of the bilayer. A
single breakthrough force (Fb) of average value 5.76 ± 0.03 nN (n=130) was found. The
representative force-distance curve and distribution of force curve obtained after analyzing
130 such force curves are shown in (Figure 3.11). The height of the bilayer was about 5
nm. After confirming the formation of SLB, 1 mL of 10 μM α-tomatine solution prepared in
PBS with a final concentration of 1.8% DMSO and 0.4% ethanol was injected through
tubing attached to a micro-volume cantilever holder ensuring complete replacement of
imaging buffer with α-tomatine containing solution. After injection, the sample was allowed
to equilibrate for 5 min and AFM images were captured continuously. Complete disruption
of the bilayer was observed within 5 min of injection of the α-tomatine. A small section of
2 x 2 μm2 was selected and imaged at the end of 60 min, a 3D representation of the section
is shown in (Figure 3.12) for easy visualization. Straw-like structures like the ones
observed in monolayer experiments could be seen confirming similarity between the
structures formed in the spread monolayers and those formed upon the interaction of αtomatine with the supported bilayer. A control experiment was conducted with just the
buffer used for preparing α-tomatine to ensure the observation was not due to the buffer
solution. No morphological and mechanical changes were observed for the initial 60 min
confirming that the disruption observed was due to the presence of α-tomatine.
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Figure 3.11. AFM topography image (A), height profile (B), and typical force-distance
curve (C) and breakthrough force (Fb) distribution for supported lipid bilayer composed of
DMPC: Cholesterol 7:3. The average Fb of 5.76 ± 0.03 nN was obtained from the
Gaussian fit.
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Figure 3.12. Changes observed in bilayer after injection of 10μM α-Tomatine at different
time interval 5 min (A), 20 min (B), 40 min (C), 60 min (D) zoomed-in image of the small
area selected after 60 min of injection (E) and 3D representation of the image in E (F).

3.3 Conclusions
L-B transfer of the monolayer composed of sterol and α-tomatine or sterol, lipid,
and α-tomatine in different molar ratios deposited at the air-water interface was done for
the visualization of complexes formed between the GA α-tomatine and sterols using AFM.
The method reported here allowed us to visualize the complexes formed at high resolution
than the previously reported methods using BAM97-98. The observed structures were
morphologically similar to the structures observed using other high-resolution imaging
techniques such as SEM19-20 and TEM107-108. AFM method described here has advantages
over these methods as it requires minimal sample preparation and can be operated under
ambient conditions of pressure and temperature.
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Further, AFM provides a unique ability to acquire high-resolution images under a
liquid environment. This capability was utilized to monitor the effect of α-tomatine on lipid
bilayer composed of DMPC and cholesterol in a 7:3 ratio. Disruption of the bilayer was
observed within 5 min of α-tomatine introduction. The method provides encouraging
results to expand the studies using other membrane-active molecules in real-time.
Furthermore, a similar experimental setup could be utilized to carry out studies in live cells
instead of model membrane systems. GAs are known to show anti-cancer activity. The
effect of GAs on the morphology and nanomechanical properties of various cancerous
cells could be further investigated.
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CHAPTER 4 SYNTHESIS, CHARACTERIZATION, AND
BIOCOMPATIBILITY STUDY OF MESOPOROUS SILICA NANOPARTICLES

4.1 Introduction
Mesoporous silica nanoparticles (MSNs) are one of the widely utilized materials
for drug delivery and cancer therapy109. MSNs because of their high specific surface area
and large pore volume can encapsulate a variety of therapeutic agents in large amounts.
The fabrication of MSNs is cost-effective, scalable, and simple. Control over various
parameters such as shape, size, and pore diameter are well established68, 110. MSNs also
provide an opportunity for surface functionalization and modification which helps in
designing a DDS with increased blood circulation time, specificity to cancer cells, and
ability of controlled drug release. Silica is approved by FDA as a Generally Recognized
as Safe (GRAS) substance and is widely used in cosmetic products and as a food additive.
All these properties make MSN promising as a candidate for a drug-delivering agent.
The project aimed to synthesize biocompatible MSNs to employ them for the safe
delivery of tomatine in the future. To this end, we synthesize amino-functionalized MSNs
(MSN-NH2) that were further coated with polydopamine and polyethylene glycol. The
hemolytic. The hemolytic activity of the nanoparticles (NP) was tested. PD and PEGcoated MSN showed no sign of hemolysis and were considered safe for intravenous
injection.
Further, the phagocytosis of MSN at different stages of functionalization and
surface modification was studied. The effect of protein corona formation in phagocytosis
was also evaluated. All tested MSN showed increased phagocytosis under corona forming
conditions with exception of PEGylated MSN. The result suggested the synthesized
nanoparticle will have prolonged blood circulation time increasing the probability of
reaching the cancer site. The uptake of nanoparticles by HepG2 cancer cells was
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visualized by confocal LSM. Moreover, the toxicity of NP after the final coating of PEG
was tested against HepG2 cells using MTT cell viability assay. The NP did not show signs
of a reduction in cell viability up to 300 µg mL-1 concentrations. The result suggested we
were able to successfully design a DDS which were non-hemolytic, showed a reduction in
phagocytosis and were non-toxic to the cells.

4.2 Result and Discussion
4.2.1 Synthesis and Characterization of MSNs
The average size of MSNs was 144 ± 1.5 nm based on TEM measurements. The
powder X-ray diffraction pattern of MSN (Figure 4.1) suggested a well-ordered hexagonal
arrangement of the pores with a lattice parameter of 4.4 nm (ao = 2d100/√3). The hexagonal
pore arrangement was apparent from the TEM micrograph. The pore diameter of the
nanoparticles from BJH analysis was calculated to be 3.7 ± 0.1 nm (Figure 4.2). SEM
images showed the spherical morphology of the MSNs (Figure 4.3). The synthesized
MSNs were functionalized with the amine group after the removal of CTAB. Post
modification MSNs designed for drug loading with various functional groups such as
carboxyl and amino is a common practice that helps in capturing the drug molecules. The
successful functionalization of the amine group was confirmed by SEM-EDX
measurements (Figure 4.4).
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Figure 4.1 Powder X-ray diffraction pattern of MSNs

Figure 4.2 BET (left) and BJH (right) analysis of MSNs along with the results
obtained
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Figure 4.3 SEM (left) and TEM (right) micrograph of MSNs
Further, a decrease in surface area and pore volume of MSN-NH2 was observed
in comparison to MSN complimented the findings of the IR study. Type IV BET isotherms
characteristic for mesoporous materials were observed for both MSNs and MSN-NH2
(Figure 4.3). The specific surface area and pore volume of MSNs were 1106 ± 1.1 m2 g-1
and 1.21 ± 0.05 cm3 g-1 respectively which decreased to 721 ± 3 m2 g-1 and 0.69 ± 0.05
cm3 g-1 after amino functionalization. TGA analysis of MSN-NH2 indicated a 7.3% increase
in the content of organic matter compared to MSNs (Figure 4.4). The weight % obtained
from TGA was in good agreement with the atomic weight percentage obtained from SEMEDX analysis (Table 1).

82

Figure 4.4 SEM-EDX analysis showing the presence of C and N atoms after amino
functionalization of MSNs.

Element

Atomic %

Atomic % Error

Weight %

Weight % Error

N

3.1

0.4

2.2

0.3

C

7.1

0.2

4.5

0.1

O

60.8

0.3

50.8

0.3

Si

28.9

0.1

42.4

0.1

Table 1. Result of SEM-EDX analysis summarizing atomic and weight percentage of
different elements present in MSN-NH2
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Figure 4.5 BET isotherms for MSNs and MSN-NH2

The MSN-NH2 was coated with PD following amine functionalization. Dopamine is
known to form a PD coating on almost any surface by self-polymerization111. At pH near
8.5, the catechol group of dopamine first oxidizes to quinone, which further reacts with
other catechol or quinone to form PD (Scheme figure? 4.1). PD-modified NPs have been
extensively used in nanomedicine as drug carriers because of their biocompatibility, high
photothermal conversion capacity, biodegradability, and their ability to act as pH-sensitive
gatekeeper112. Further, PD provides a convenient platform for secondary modifications.
Nucleophiles such as thiols and amine can be immobilized on the PDA layer through the
Michael addition or a Schiff base reaction. The coating of NP with the PD layer was
confirmed by TEM. The particle size distribution analysis indicated about 10 nm thick layer
of PD was coated on the surface of MSN-NH2@PD (Figure 4.5).
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Figure 4.5 TGA of MSNs at different stages of functionalization and surface
coating

Figure 4.7 Mechanism for polymerization of dopamine to polydopamine (top). The
polymerization process is visible as the color of the solution gets darker after the formation
of polydopamine is its structure correct as drawn with no double bond in the five-
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membered ring?. The mechanism for PEGylation (bottom). PEG with amine group can be
immobilized on the PDA layer through the Michael addition or a Schiff base reaction.

Finally, the NPs were coated with PEG molecules. PEGylation of the NP is shown
to reduce phagocytosis and increase blood circulation time. The average size of NP after
PEG coating was 160 ± 1.9 nm with about 16 nm of polymer coating (Figure 4.5). TGA
analysis was done to calculate the percentage of polymer coated on the surface of the
NPs (Figure 4.4). The total weight % of the polymer after two steps of polymer coating
was calculated to be 9.6 ± 1.3.

Figure 4.8 TEM micrographs of MSN (A), MSN-NH2 (B), MSN-NH2@PD (C), MSNNH2@PD/PEG (D). The size distribution of the NP based on >100 measurements MSN
(A’), MSN-NH2 (B’), MSN-NH2@PD (C’), MSN-NH2@PD/PEG (D’).
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4.2.2 Hemolysis assay
The biocompatibility of nanomaterials expected to interact with biological systems
is extremely important. For a DDS designed to be injected intravenously, it is therefore
required that the system be non-hemolytic. Assessment of the hemocompatibility of
synthesized MSN at different stages of functionalization and surface modification was
carried out using human RBC. A significant reduction in hemolysis was observed upon PD
and PEG modification of NP (Figure 4.6). Both MSN-NH2@PD and MSN-NH2@PD/PEG
were < 2% hemolytic at the highest experimental concentration of 800 μg mL-1. Hence, it
could be inferred that the designed DDS could be used for the safe delivery of drugs
intravenously.

Figure 4.9 Hemolytic activity of NPs at different stages of synthesis and surface
modifications.

4.2.3 Phagocytosis of NP
The clearance of nanomaterials designed for therapeutic and/or diagnostic
purposes by phagocytes is a major problem in nanomedicine113. Adsorption of protein on
the surface of NP upon contact with biofluids results in the formation of protein corona
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which triggers phagocytes and initiates phagocytosis of NP. The amount of protein
adsorbed, and the conformation of adsorbed proteins depends upon the physicochemical
properties of nanoparticles such as size, geometry, surface functionality, and surface
charge. An ideal DDS should be less prone to phagocytosis and have increased blood
circulation time.
The influence of functionalization and surface modification in the phagocytosis of
NP was evaluated using human THP-1 macrophages. No significant recognition of NP by
THP-1 macrophages was observed in non-corona forming conditions with exception of
MSN-NH2 (Figure 4.7). Positively charged NP are reported to be taken up by macrophages
at a higher degree compared to negative or neutral NP113-115. It has been hypothesized
that macrophages bear negatively charged sialic acid on their surface which binds to
positively charged NP115. Although our preliminary observation supports the hypothesis,
not much information is available on DDS based on MSNs and requires more investigation
which is beyond scope of the present study116. On the other hand, a larger number of NP
were present on the surface of THP-1 macrophages under the corona forming conditions
except for MSN-NH2@PD/PEG (Figure 4.7) indicating a reduction in phagocytosis of NP
upon PEGylation.
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Figure 4.10 Phagocytosis of NP by THP-1 macrophages Phalloidin-iFluor 555 was used
to label actin filaments shown in red, DAPI was used to stain nuclei shown in blue, and
NPs were labeled with fluorescein shown in green.

4.2.4 Cellular internalization and toxicity evaluation of MSN-NH2@PD/PEG
The cellular uptake of MSN-NH2@PD/PEG by HepG2 cells was visualized by
confocal LSM using fluorescence-labeled NP after 3 h of incubation. The internalization of
NP was apparent (Figure 4.8). Further, an increase in actin filament polymerization was
observed in the cells treated with NP compared to untreated cells suggesting actindependent endocytosis. An increase in cellular uptake of MSNs upon PEGylation through
actin-dependent pathway has been previously reported117. Similarly, bundling of actin
filament upon exposure to magnetic nanoparticles has also been observed118. The
cytotoxicity of MSN-NH2@PD/PEG was tested using an MTT cell proliferation assay. The
percentage of viable cells was greater than 95% for all concentrations except at 300 μg
mL-1, the highest concentration tested, at which only 65% of cells were viable. Based on
the result of the cell viability assay it could be concluded that MSN-NH2@PD/PEG are
non-toxic to the cells at concentrations of <300 μg mL-1.
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Figure 4.11 Visualization of cellular internalization of MSN-NH2@PD/PEG by HepG2
cells. Actin filaments were labeled with Phalloidin-iFluor 555 shown in red, the nucleus is
labeled with DAPI shown in blue, and MSNs were fluorescein-labeled shown in green.

4.3 Conclusions
MSNs with a pore diameter of 3.7 nm, pore volume of 1.21 cm3 g-1, and specific surface
area of 1106 m2 g-1 were synthesized. The average diameter of NP was 144 nm. The
MSNs as-synthesized were hemolytic. The NPs were further amino-functionalized and
coated with PD and PEG. A significant reduction in hemolysis of RBCs upon polymer
coating was observed. The reduction in hemolysis would allow the application of such
porous material for intravenous drug delivery. Further, it was observed that upon
PEGylation the nanoparticles were not recognized by macrophages of the immune
system. The reduction in phagocytosis of NPs designed for drug delivery is a desired
property that increases the circulation time of the NPs in the blood increasing their chance
of reaching the cancer location. The average size of NPs upon PEG coating was 160 nm,
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which is in the range suitable for the EPR effect (enhanced permeability and retention) for
accessing cancer cells through leaky vasculature.

91

CHAPTER 5 MESOPOROUS SILICA NANOPARTICLES FOR
LOADING AND SAFE DELIVERY OF Α-TOMATINE FOR EFFECTIVE
TREATMENT OF HEPG2 CANCER CELL IN VITRO

5.1 Introduction
Plant-based natural products have been widely used by mankind since ancient
times until the present day119. Nearly 25% of pharmaceutical compounds available today
are derived from natural products. Several synthetic drugs available or under development
draw their inspiration from natural products. Various computational studies are being
conducted to simplify complex natural product structures in small fragments with potential
therapeutic application120. While studies are being conducted to develop synthetic
therapeutic drugs based on natural products the use of plant extracts is declining121.
Although natural products have advantages over synthetic chemicals such as low side
effects and costs, their lack of bioavailability, poor solubility, low stability, lack of targetspecific delivery, and poor absorption in the body resulted in the loss of interest. To this
extent, the application of recent drug delivery systems and strategies can solve most of
these problems.
Herein we report the synthesis of DDS consisting of tomatine-loaded MSNs coated
with PD and PEG. α-Tomatine a GA found in tomato plants, especially in green fruits,
leaves, and stems were used as a representative natural product. Glycoalkaloids such as
α-tomatine (the designation alpha refers to the compound with the fully intact
tetrasaccharide) are known to bind strongly to 3β-hydroxy sterols such as cholesterol and
perturb membrane structure in a manner that can result in the leakage of cellular contents.
The developed drug delivery system showed a remarkable decrease in hemolytic activity
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when compared to free tomatine. The effectiveness of the developed system was tested
against human HepG2 cells. A significant reduction in viability of cells was observed in the
concentration range of 1.6 to 12.7 μg mL-1. The effectivity was comparable to free tomatine
at the same concentration range. The result from apoptosis/necrosis assay indicated a
sign of late apoptosis which was further confirmed by an increase in cell viability upon the
addition of 1 μM of poly caspase inhibitor, QVD-OPh along with the tomatine loaded MSN
(MSN-NH2-Tom@PD/PEG).
A significant reduction in hemolysis was observed for MSN-NH2-Tom@PD/PEG
in comparison to free tomatine. MSN-NH2-Tom@PD/PEG showed < 5% hemolysis at the
highest experimental concentration of 10 μg mL-1. Further, the phagocytosis of MSN at
different stages of functionalization and surface modification was studied. The result of the
research is intended to encourage the application of DDS based on nanomaterials in the
field of natural product therapeutics.

5.2 Results and Discussions
5.2.1 Loading of Tomatine in MSNs
Various steps involved during synthesis, functionalization loading, and surface
modification of the DDS are shown in Figure 5.1. The amount of tomatine loaded inside
MSN-NH2 was estimated using TGA (Figure 5.2). Percentage weight change between 100
o

C and 650 0C was used to calculate the weight % of tomatine inside NP. Initially, a loading

of 8.0 % was observed. The observed loading was a significant improvement compared
to unfunctionalized MSNs in which no loading was detected. Although molecules tend to
adsorb inside the pores of MSN, an increase in loading upon amino functionalization has
been reported. Increased loading of curcumin upon amino functionalization of different
types of MSN has been reported previously122. In another study, a similar result was
obtained in which the functionalization of MSN with amino groups resulted in increased
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loading of betulinic acid due to the formation of weak intermolecular interaction between
the amine group and polar groups of betulinic acid123. A loading of 4.2 % was achieved
after the final coating of MSN with PEG molecules. A loss of 3.8 % which accounts for
about 47.5 % of initially loaded tomatine occurred during polymer coating of the NP.

Figure 5.1 Scheme representing various steps involved in the designing of DDS.
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Figure 5.2 TGA of nanoparticles after amino functionalization, loading of tomatine, and
polymer coating.

The specific surface area of NP decreased to 136±10 m2g-1 after tomatine loading.
The nitrogen adsorption-desorption isotherm resembled that of type II (Fig. 2)
corresponding to non-porous materials indicating blocking of the pores by adsorbed
tomatine. Further, a decrease in pore volume from 0.69±0.05 cm3 g-1 to 0.24±0.02 cm3 g1

confirmed that the pores of NP were occupied by tomatine. The appearance of peaks

near 1450 cm-1 corresponding to C – H bending of the methyl group, between 1390 cm-1
and 1315 cm-1 corresponding to O–H bending of alcohol, at 1630 cm-1 corresponding to
N–H bending of amine group along with C–H stretching between 2973 cm-1 and 2973 cm1

in the IR spectrum which resembled the peaks on the IR spectrum of tomatine (Figure

5.2) also confirmed the loading of tomatine in MSN-NH2.

Figure 5.3 FTIR spectra of MSN, MSN-NH2, MSN-NH2-Tom, and tomatine
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5.2.2 Reduction in Hemolysis due to Tomatine
A significant reduction in the hemolytic activity of tomatine was observed upon its
entrapment inside the MSN-NH2. MSN-NH2—Tom@PD/PEG showed hemolysis of 4.6 %
at the concentration of 10 μg mL-1 which was more than 20-fold less than free tomatine at
the same concentration (Figure 5.3). The observed result indicated MSN-NH2—
Tom@PD/PEG were hemocompatible and could safely be injected. Free tomatine showed
> 5 % hemolysis up to 2 μg mL-1 and hemolysis of 2.2 % were observed at 1 μg mL-1, a
concentration at which no significant cellular toxicity was observed (vide infra). Hence, it
could be inferred that the designed DDS could be used for the safe delivery of tomatine at
concentrations effective to treat cancer cells.

Figure 5.4 Comparison of hemolytic activity of free tomatine and MSN-NH2Tom@PD/PEG. Data are shown as Mean ± SEM of two independent experiments
performed in triplicate (n=6).
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5.2.3 Cell Viability Assay
Dose-dependent cytotoxicity was observed based on the results from the MTS
assay (Figure 5.4). Further, the effectiveness of the MSN-NH2-Tom@PD/PEG was
compared with the free tomatine. The results indicated no significant difference between
the two except at 12.7 μg mL-1, the highest concentration tested, at which MSN-NH2Tom@PD/PEG was more effective than free tomatine. The IC50 of tomatine was calculated
to be 1.8±0.4 μg mL-1 (Figure 5.5). The cytotoxicity of MSN-NH2@PD/PEG was tested as
a control. The percentage of viable cells was greater than 95% for all concentrations
except at 300 μg mL-1 at which only 65% of cells were viable. The 300 μg mL-1
concentration of MSN-NH2@PD/PEG is equivalent to 12.7 μg mL-1 of tomatine in MSNNH2-Tom@PD/PEG (based on 4.2% loading). The IC50 value of MSN-NH2-Tom@PD/PEG
was calculated to be 1.62 ± 0.04 μg mL-1 (Figure 5.5). From the result of the MTS assay,
it could be concluded that the effectiveness of MSN-NH2-Tom@PD/PEG was comparable
to free tomatine and the concentration ranging between 1.6 μg mL-1 and 6.3 μg mL-1 of
tomatine which corresponds to 37.5 μg mL-1 to 150 μg mL-1of MSN-NH2-Tom@PD/PEG
would be a safe dose that can be used for effective treatment of HepG2 cells.
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Figure 5.5. Visualization of cellular internalization of MSN-NH2@PD/PEG by HepG2 cells.
Actin filaments were labeled with Phalloidin-iFluor 555 shown in red, the nucleus is labeled
with DAPI shown in blue, and MSNs were fluorescein-labeled shown in green (A). Cell
viability assay performed using MTS assay (B). Data are shown as Mean ± SEM of two
independent experiments performed in triplicate (n=6). The pairs with p < 0.05 are marked
with *.
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Figure 5.6. Calculation of IC50 values for tomatine-loaded MSNs (MSN@Tom), free
tomatine (Tom), and tomatine-loaded MSNs in the presence of caspase inhibitor.

5.2.4 Apoptosis/ Necrosis Assay and Effect of Caspase Inhibition in Cell Viability
The inhibitory effects of tomatine on the proliferation of various cancer cells have
been reported and both apoptotic and necrotic pathways have been suggested as a
possible mode of action7,
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. Therefore, apoptosis/necrosis assay was performed to

distinguish between the two purposed possibilities. The assay is based on the use of a
phosphatidylserine (PS) sensor, apopxin green, that binds to PS exposed on the surface
of apoptotic cells. The cells were co-stained with 7-aminoactinomycin D (7-ADD), a
membrane-impermeable DNA labeling dye, and CytoCalcein Violet 450, cell cytoplasm
labeling dye. 7-ADD impermeable to healthy cells can enter the necrotic cells with
compromised membrane integrity and thus label the nucleus. CytoCalcein Violet 450 was
used for labeling healthy cells. The cells were visualized using confocal LSM after 30 min
of incubation. The results were interpreted according to the guidance provided by the
manufacturer (Abcam Inc.). Briefly, cells positive to apopxin green were designated as
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apoptotic, cells positive to 7-ADD as necrotic, cells positive to cytocalcein violet as healthy,
and cells positive to both apopxin green and 7-ADD were labeled as late apoptotic cells.
A significant increase in the number of late apoptotic cells was observed in the
samples treated with MSN-NH2-Tom@PD/PEG compared to the control group treated
with MSN-NH2@PD/PEG (Figure 5.6). The concentration of tomatine in MSN-NH2Tom@PD/PEG treated cells were 1.6 μg mL-1 (based on 4.2% loading) and an equivalent
amount of MSN-NH2@PD/PEG (37.5 μg mL-1) was used for the control experiment. The
cells were incubated with MSN-NH2-Tom@PD/PEG in the presence of a poly caspase
inhibitor QVD-OPh, to validate the above interpretation and to evaluate the role of caspase
in the observed apoptosis.
Caspases are a large family of evolutionarily conserved cysteine aspartates that
recognize short-chain peptide molecules and uses a nucleophilic cysteine in their active
site to cleave amino acid after an aspartate residue124-125. So far there are 12 known
caspases in humans126. Caspases play an important role in apoptosis and a wide range
of caspase inhibitors are available to ascertain the role of caspases in programmed cell
death124. QVD-OPh is one of such poly caspase inhibitors and is known for its ability to
effectively inhibit all caspases except caspase 4 at 1 μM concentration124. We observed
that the addition of 1 μM QVD-OPh together with MSN-NH2-Tom@PD/PEG resulted in a
significant increase in the number of viable cells (Figure 5.6). The results suggested
caspase-mediated apoptosis as a possible cause of observed cell death. The ability of
tomatine to induce activation of caspase when used alone or in combination with
chemotherapeutic agents such as paclitaxel has been reported previously7, 127 and is in
corroboration with the present findings.
The effect of QVD-OPh in cell proliferation was further quantified by cell viability
assay. We observed that the addition of 1 μM QVD-OPh together with MSN-NH2Tom@PD/PEG resulted in a significant increase in the percentage of viable cells at three
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different concentrations (Figure 5.6). The highest difference in the percentage of viable
cells was observed for 1.6 μg mL-1 of tomatine, where the percentage of viable cells
increased from 50.3% to 88.0% in the presence of QVD-OPh. It should be noted that,
although the presence of QVD-OPh showed statistically significant improvement in cell
viability at the other two concentrations, 3.2 μg mL-1, and 6.3 μg mL-1, it was not able to
prevent cell death. Based on these observations it would be logical to conclude that the
cells showed signs of apoptosis and caspases mediated apoptosis might be one plausible
cause of cell death. Further investigations dedicated to understanding the molecular
mechanism of cell death are required.
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Figure 5.7. Apoptotic, necrotic, and healthy cells were visualized after treating HepG2 cells
with 1.6 μg mL-1 of tomatine (in MSN-NH2-Tom@PD/PEG) in the presence or absence of
caspase inhibitor, QVD-OPh (A). Cells treated with an equivalent concentration of NP
without tomatine were used as control. Apoptotic cells were labeled with apopxin green
shown in green, healthy cells were labeled with cytocalcein violet 450 shown in blue and
necrotic cells were labeled with 7-ADD shown in red. The difference in cell viability upon
addition of caspase inhibitor, QVD-OPh (B). Data are shown as Mean ± SEM of two
independent experiments performed in triplicate (n=6). The pairs with p < 0.05 are marked
with * (*p<0.03, **p<0.002, ***p<0.0002).

5.3 Conclusions
A DDS based on MSNs was developed for safe delivery of GA, α-tomatine, and its
effectiveness against HepG2 cells was evaluated. A remarkable reduction in hemolysis
was observed upon loading of tomatine inside MSNs modified with PD and PEG which
assured safe intravenous delivery of tomatine at concentrations effective for the treatment
of HepG2 cells. The effectiveness of the DDS was comparable to free tomatine but with
the added benefit of reduction in hemolysis. Further, there are possibilities of decorating
the DDS with ligand, specific to receptors overexpressed in cancer cells for targeted
delivery of drugs.
Natural products provide an excellent alternative for the treatment of various
diseases including cancer with the added benefit of low side effects, low cost, and easy
availability which could be beneficial especially in the case of developing and
underdeveloped countries with limited resources. GAs are one of such potential
candidates with readily available plant sources such as tomatoes (α-tomatine), potatoes
(α-chaconine and α-solanine), and eggplant (α-solamargine and α-solasonine) to name
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some. To this extent, only a few studies with the use of nanomaterials for delivery of GA
extracts for cancer treatment are reported128-129. We hope that the present study provides
aid and inspiration for the design and development of novel therapeutic nanodevices for
the fruitful incorporation of natural products from plant extracts in cancer treatment.
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CHAPTER 6 MISCELLANEOUS WORK
6.1 Application of AFM from Material Characterization to Studying
Biological Samples
AFM has served as an important tool for studying properties of myriad samples
ranging from research in material to biological sciences51,
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. AFM can be used for

investigating various surface properties such as friction, adhesion forces, magnetic and
electrostatic properties, Young modulus, and viscoelastic properties. The technique is
useful for analyzing almost any kind of samples such as thin films or fibers, powders,
polymers, adsorbed molecules under air, vacuum, or liquid medium. AFM requires minimal
sample preparation and it requires relatively low cost for operation and maintenance when
compared to other high-resolution imaging techniques such as SEM and TEM. The
resolution of AFM is in atomic scale and is a non-destructive imaging technique.
The chapter discusses some of the AFM studies carried out to characterize the
surface of a silicon wafer prepared as solid support for the attachment of a gold film free
of an intermediate layer. Similarly, in AFM was utilized to study the morphology of the
NPG surface and how the surface is changed after loading DOX.
Some of the preliminary results of the AFM study of RBC and HepG2 cells are also
presented. The study aimed to investigate the morphological and mechanical changes
that occur upon their interaction with α-tomatine. The hemolytic nature of α-Tomatine and
its effectiveness against HepG2 cells was established during an earlier study and the goal
of this project was to have visual evidence of such event. The protocol used for imaging
is mentioned in Chapter 2. The present chapter discusses the areas to improve and
modifications that could be done to improve the result for continuation of the project.
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6.2 AFM to Characterize Surface of Silicon Wafer
The result presented below is the part of the project published in 2020 in the journal
Sensors and Actuators A : Physical131. The broad goal of the project was to develop a
method to attach a film of gold on the surface of the silicon wafer without an intermediate
adhesion layer between the two. The film of gold deposited on silicon substrate does not
bind strongly which requires the presence of an intermediate adhesion layer. Traditionally
a metallic (eg., Cr or Ti) or an organic (eg., silanes or polymer) adhesion layer is applied
on the silicon substrate before the deposition of the gold film. However, for gold films
deposited to design plasmonic–active sensors presence of such intermediate layer
dampens the plasmonic response reducing their sensitivity. The presence of such an
intermediate layer, therefore, is not desired.
The problem was tackled by roughening of silicon surface before deposition of the
gold film. The surface was roughened by scratching and etching in 10 M NaOH for 20 min.
The fabricated plasmon active nanostructured thin film of gold (PANTF-Au) was further
used to study the interaction between lectin and glycoprotein as the proof-of-concept
design for the point of care biosensor.
AFM was very useful in the characterization of the surface roughness and for
understanding the reason for the stable attachment of gold film on the scratched-etched
silicon surface (Figure 6.1). It was concluded that the formation of island-like features
composed of a collection of granular structures in the scratched-etch silicon wafer resulted
in improved stability of gold film attachment because of enhancement in nucleation sites
for the gold atom to form gold films. AFM was used as complementary to SEM and
provided additional information on surface roughness.
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Figure 6.1 SEM images at low (A) and high (B) magnification and AFM topography image
(C) of scratched silicon wafer the generated roughness profile is shown below C. SEM low
(D) and high (E) magnification images and AFM topography image (F) of scratch-etched
silicon wafer the generated roughness profile is shown below F.

6.3 AFM to Characterize NPG
The result presented below is the part of the project published in 2021 in the journal
Nanomaterials132 . The goal of the project was to develop an implantable drug delivery
system. NPG millirods were fabricated by the chemical dealloying method. Thus, formed
NPG millirods were loaded with DOX and were then encapsulated by poly (D, L-lactide106

co-glycolide) (PLGA, lactide: glycolide = 65:35, MW 40-75 kDa) containing rapamycin
(RAPA) using the dip-coating method. The developed implantable DDS exhibited
sustained co-release of DOX and RAPA. The devised DDS demonstrated that nanoporous
gold-based implants have the potential to be used as a drug carrier for cancer treatment.
AFM was used to study the morphology of NPG and to compare the surface of
NPG before and after loading of DOX (Figure 6.2). The AFM images of DOX-loaded NPG
showed an increase in roughness. Further, height distribution analysis indicated an
increase in height of 2.4 nm after DOX loading suggesting the presence of DOX molecule
on NPG surface and may have been dimerized.
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Figure 6.2 AFM topography images of NPG before (A) and after (B) DOX loading and their
corresponding 3D view and height distribution profile on the right

6.4 AFM Study of RBC and HepG2 Cells
The development of electron microscopy techniques has improved the resolution
with which cellular features can be observed. The improvement is remarkable when
compared to light microscopic techniques where the resolution is restricted due to the
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optical diffraction limit. However, the preparation of biological samples is complicated and
destructive, and the observation of live samples is not possible133. To this end, AFM
microscopy provides an opportunity to visualize biological samples in their native
environment with atomic-scale resolution134-136.
RBC is also known as erythrocytes play an important biological function of
transporting oxygen from the lungs to the body tissue and carbon dioxide from tissues to
the lungs. Healthy human RBCs are biconcave (discocyte) shaped with an approximate
diameter of 8 µm and thickness of 2 µm137. The morphology of RBC changes as a function
of its environment, pathological condition, and age. It has been found that the RBC exists
as stomatocytes (cup shape) form in hypotonic solution and as echinocytes in hypertonic
solution (Figure 6.3)138. AFM was first used to image RBC by Butt et al.139 and Gould et
al.140 in 1990. Since then AFM is used to image nanostructures on the surface of RBC and
morphological and mechanical differences between healthy and pathological RBC
samples133.

Figure 6.3 3D confocal images of the canonical shapes of RBCs in different concentrations
of NaCl. From left to right: 55, 80 (two stomatocytes), 154 (one discocyte), 200, 250, 300,
and 350 mM NaCl (four echinocytes). Reproduced from reference138.
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RBC because of their soft membrane can deform when they come in contact with
AFM probes. Fixation of RBC is therefore required for acquiring a high-resolution image.
The immobilization of samples on an atomically flat solid support is essential for AFM
imaging. For this poly-L-lysine is commonly used for coating the surface of glass slides.
Poly-L-lysine provides a poly-cationic surface for the attachment of negatively charged
glycocalyx coating of the cell surface.
The result of AFM images acquired is presented in Figure 6.4. The majority of RBC
appeared as echinocytes while few discoytes were also observed. The morphological
appearance of the discoyte cell, diameter, and thickness was in the normal range. One
possible explanation for the presence of high echinocytes could be the use of a
concentrated solution of glutaraldehyde during fixation of RBC, which might have
increased in osmolality of PBS solution. Such effect of increased osmolality upon addition
of glutaraldehyde in the morphology of RBC has been reported where the RBC fixed in
1% glutaraldehyde appeared flattened and had borders slightly spiky, resembling
echinocytes141. Therefore, the application of a low concentration of glutaraldehyde would
be the next logical step for the optimization of the protocol. The overall goal of the project
was to visualize morphological differences upon treatment of RBC with different GA and
the establishment of an optimal protocol for getting a morphologically correct image of the
control sample was the first step toward the goal.
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Figure 6.4 AFM images of RBC taken in contact mode in fluid

Similarly, efforts were made to visualize HepG2 cancer cells and the effect of αtomatine treatment in the morphology using AFM. The results are presented in Figure 6.5.
We could visualize the morphological difference between the untreated and treated cells.
The tomatine-treated cells appeared spherical and the presence of blebbing on the cell
surface could be visualized, these traits are typical for apoptotic cells and the results were
complementary to the observation made in our previous studies. The results are promising
although some improvement is required for the preparation of the sample. The presence
of pits on the cell surface of the control cells suggests significant damage was done to the
cells during sample preparation. One possible way of avoiding such damage is to grow
the cells directly on sterile glass slides which can be mounted on the AFM pucks and
would avoid trypsinization and centrifugation steps. The Bioscope Resolve instrument can
111

image samples in a petri dish, therefore, growth, treatment, and fixation of cells could be
done on a cell culture dish and be imaged without the requirement of transferring it to the
substrate. Further, the possibility of imaging on a petri dish allows the opportunity to image
live cells and observe the effect of treatment in real-time.

Figure 6.5 AFM images of HepG2 cells before (left) and after (right) α-Tomatine
treatment

6.5 Conclusions
AFM was utilized to characterize the surface of the silicon wafer and NPG. AFM
was valuable for quantifying the surface properties as roughness and height distribution
and the data generated helped confirm the results obtained by SEM.
Further, the potential application of AFM to study the effect of GAs on RBCs and
HepG2 cells was explored. The preliminary results suggested upon optimization of sample
preparing conditions the proposed experiments are feasible. Possible areas for
improvement based on the literature survey and the instrumental capacity are suggested.
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